康哲药业:肾性贫血新药德昔度司他片中国获批上市

深圳, 2026年3月13日 - (亚太商讯 via SeaPRwire.com) - 康哲药业控股有限公司(867.HK/8A8.SG)("康哲药业")欣然宣布,肾性贫血新药德昔度司他片(原名:德度司他片)("产品")上市许可申请已于2026年3月13日获得中国国家药品监督管理局(NMPA)批准。产品为一种创新型口服低氧诱导因子-脯氨酰羟化酶抑制剂(HIF-PHI),适用于非透析的成人慢性肾脏病(CKD)患者的贫血治疗。德昔度司他片获批上市,将进一步强化康哲药业在肾病专科领域的整体布局,并与处于商业化阶段的创新药维福瑞(蔗糖羟基氧化铁咀嚼片,用于CKD高磷血症)协同增效。通过肾内科专家资源与渠道网络的高效联动,康哲药业有望快速推动德昔度司他片的规模化临床应用,为中国CKD肾性贫血患者提供差异化的治疗选择,为集团业绩带来积极贡献。关于德昔度司他片和肾性贫血的更多信息作为一种创新型口服HIF-PHI,产品作用机制为通过增加内源性促红细胞生成素的生成、改善铁的利用率和降低铁调素的水平来促进红细胞生成。其中国III期临床试验取得了积极结果。主要研究终点血红蛋白(Hb)水平(第7-9周Hb平均值相对于基线的变化)结果显示,试验组优于安慰剂组。扩展期研究结果显示,产品可使Hb水平长期维持在达标水平,且安全性良好。此外,产品还可以显著降低铁调素水平,纠正铁代谢紊乱。中国CKD贫血治疗领域仍存在显著的未被满足需求。据估计,中国有超过1.2亿CKD患者[1],贫血作为其常见并发症之一,发生率随病程进展呈逐步升高趋势。国内一项调研显示,CKD1~5 期患者贫血患病率依次为:22.0%、37.0%、45.4%、85.1%和98.2%[2]。血液透析CKD贫血患者的治疗达标率(Hb水平达到靶目标值(110~120 g/L))已提升至51.5%[3],但对于非透析CKD贫血患者来说仍仅为8.2%[4]。产品采用口服给药,有望提高患者的治疗顺应性,有望满足CKD贫血领域未被满足的治疗需求。产品已在印度获批上市。康哲药业之全资附属公司康哲国际发展管理有限公司通过生效日为2020年1月20日的《许可协议》从Zydus Lifesciences Limited(前称为Cadila Healthcare Limited)处获得产品的独家许可权利。康哲药业坚持 "创新驱动" 核心战略,已构建起梯队衔接、储备充足的立体化创新产品矩阵:7款新药获批上市、6款正处于上市审评阶段、近20个项目即将开展/正在推进临床试验。康哲药业通过"合作开发+自主研发"双轮驱动创新,持续丰富以全球首创(FIC)、同类最优(BIC)产品为核心的创新管线,高效推进临床开发与商业化落地。未来,康哲药业将继续以临床需求为导向,提供更多优质医药解决方案,坚定向专科聚焦、创新卓越的国际化医药企业迈进。关于康哲药业康哲药业是一家链接医药创新与商业化,把控产品全生命周期管理的开放式平台型企业,致力于提供有竞争力的产品和服务,满足尚未满足的医疗需求。康哲药业专注于全球首创(FIC)及同类最优(BIC)的创新产品,并高效推进创新产品临床研究开发和商业化进程,赋能科研成果向诊疗实践的持续转化,造福患者。康哲药业聚焦专科领域,拥有被验证的商业化能力,广泛的渠道覆盖和多疾病领域专家资源,核心在售产品已获领先的学术与市场地位。康哲药业围绕优势专科领域不断纵深发展,以巩固心肾代谢/消化/眼科/皮肤健康业务竞争力,带来专科规模效率,其中皮肤健康业务(德镁医药)已成为其细分领域的龙头企业,并拟于联交所独立上市。同时,康哲药业持续推动研产销全产业链在东南亚及中东区域运营发展,以获取新兴市场的增量,助力集团实现高质量可持续发展。参考文献/资料1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-62. 肾性贫血诊断与治疗中国专家共识(2014修订版)[J]. 中华肾脏病杂志, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.0153. 中华医学会肾脏病学分会第十九届重症肾脏病与血液净化大会(2025年7月2-5日)4. 肾性贫血诊断与治疗中国专家共识(2018修订版)[J]. 中华肾脏病杂志, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广,非广告用途。本新闻不对任何药品和医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息,请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请,不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制,但康哲药业并无进行任何说明或保证、明述或暗示,或其他表述,对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述,该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证,存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测,康哲药业对该等第三方声明及预测不承担责任。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating “Online x Offline” O2O Community Finance Strategy

HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – uSmart Securities Limited ("uSMART Securities/the Company") is pleased to announce the official opening of its ninth and tenth physical service centres in Tai Wai and Tuen Mun. Within just one year, uSMART Securities has expanded its Hong Kong service network to 12 physical service centres, surpassing industry benchmarks and actively implementing its "Online x Offline" (O2O) community finance strategy. This expansion solidifies its position as the “No.1 Hong Kong Funded Fintech Brokerage^” and further enhances brand influence.Promoting Accessible Community Financial ServicesThe Tuen Mun branch held a simple yet meaningful opening ceremony today, marking the official commencement of services and a new chapter in the Company's development. Mr. Neo Lee, Executive Director of uSMART Securities, stated: "The opening of the Tai Wai and Tuen Mun branches represent a crucial strategic move in our commitment to local communities and advancing community-oriented services. We focus not only on network coverage but also on connecting with the community, upholding our 'customer-centric' philosophy. By bridging the gap with residents, we are advancing toward our goal of 'seamless coverage across Hong Kong'."(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)Comprehensive Coverage Across Hong Kong 18 DistrictsAiming to accelerate the goal of becoming "the Fintech brokerage with the most service centres in Hong Kong," uSMART Securities will open branches in core areas, Kai Tak and Mong Kok in the second quarter. The company is also actively exploring pop-up stores in shopping malls and participating in various exhibition booths. Through multi-channel engagement with customers across different districts, the company aims to refine its regional presence, enabling citizens across all 18 districts to easily access professional and personalized investment and wealth management services, seamlessly integrating financial experiences into daily life.Diversified Investment ProductsAt the opening ceremony, Neo revealed that uSMART Securities has recently obtained a futures trading license and is preparing to launch futures trading services by mid-year. Upon launch, clients will be able to trade futures, including index futures, commodity futures, and currency futures via the uSMART platform. This expansion provides investors with a more comprehensive range of investment products covering long-term, medium-term, and short-term investments, as well as low, medium, and high expected returns, catering to diverse client needs.Futures services will be fully integrated into the existing uSMART APP trading platform, allowing clients to trade US and Hong Kong stocks, futures, ETFs, funds, and discretionary investment products from a single APP. This enables diversified asset allocation, risk management, and wealth enhancement services, allowing clients to utilize capital efficiently and manage investment portfolios flexibly, truly achieving "one-stop wealth management with comprehensive asset allocation."Promoting Investment Education and Enhancing Client InteractionuSMART Securities is also committed to advancing investor education, regularly hosting various online and offline investment seminars and thematic events such as wine tastings and cocktail workshops. These initiatives deepen client engagement and relationships, enhancing customer retention and loyalty.Meanwhile, a new financial channel led by stock commentator and Executive Director of Research, Mr. Dickie Wong, will officially launch next Monday (March 16). Before the market opens and midday close on every Hong Kong stock trading day, a professional team will provide you with real-time analysis of market dynamics and investment opportunity. uSMART Securities aims to foster closer interaction, helping clients refine their practical skills, optimize investment decisions, and build a more comprehensive platform for learning and practice.Expanding Team SizeIn line with rapid business growth, uSMART Securities is actively advancing local talent recruitment and training. The company expects to increase its workforce by 30% over the next two years across areas including branch operations, product design, wealth management, compliance and risk control, and marketing operations. This expansion aims to enhance team scale and professional capabilities, driving steady business growth.Looking ahead, uSMART Securities will continue to optimize trading experiences and strengthen synergies between offline service points and community activities, further solidifying its leading position in financial technology. By combining innovative technology with community networks, the company strives to provide more convenient and personalized wealth management services for investors of all ages and experience levels, promoting the popularization and intelligent development of Hong Kong's financial ecosystem.^”No.1 Hong Kong Funded Fintech Brokerage" is based on TradeGo Cloud data, with uSMART Securities ranking first in monthly transaction volume among local Hong Kong-funded internet brokers for over a year as of February 2026.About uSMART:uSMART Securities is a leading Hong Kong Funded Fintech Brokerage founded in 2018. Over the past eight years, it has pioneered the fusion of technology and finance, offering stocks trading, asset management, and wealth management solutions. Its proprietary platforms, uSMART HK APP and uSMART SG APP, operated by uSMART Securities (Hong Kong) and uSMART Securities (Singapore) respectively. It supports investments in Hong Kong stocks, US stocks, A-shares (via Shanghai and Shenzhen Stock Connect), Singapore Stocks, Japan Stocks, UK Stocks, US options, ETFs, Funds, Bonds, Asset Management, Structured Notes, Futures, Crypto, Precious Metals, Gold, and forex. Furthermore, uSMART is equipped with a highly professional research and asset management team that offers asset management, wealth management, securities brokerage, institutional business, LPF services, and investment banking, dedicated to serving ultra-high-net-worth individuals and families, corporations, investment institutions, fund companies, and other brokerage firms with comprehensive asset management solutions.For details please visit: https://hk.usmartglobal.comFor any media queries, please contact:Carrie Wong9788 4665carriewong@usmart.hk Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo

SHENZHEN, CHINA, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health, which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix®) (the “Product”, marketed as Opzelura® in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. The prescriptions cover approximately a thousand influential public and private medical institutions in the field of skin health and disease management, including Huashan Hospital, Fudan University, Shanghai Skin Disease Hospital, Dermatology Hospital of Southern Medical University, Second People's Hospital of Chengdu, The First Bethune Hospital of Jilin University, The Second Xiangya Hospital of Central South University, United Family Healthcare Group, among others*. Meanwhile, the Product has become concurrently accessible via over 1,300 offline drugstores as well as JD.com e-commerce platform. *Hospital rankings are listed in no particular order.As the first topical JAK inhibitor approved in China for the treatment of vitiligo, ruxolitinib phosphate cream has officially launched its large-scale clinical application today, marking a breakthrough in China’s vitiligo treatment landscape and ushering in a new era of precision targeted therapy for vitiligo. Supported by safety and efficacy fully demonstrated in clinical studies, the Product is expected to bring new hope for repigmentation to millions of vitiligo patients.The rapid commercialization progress of ruxolitinib phosphate cream underscores strong product operation capabilities of CMS (including Dermavon), while also reflecting the robust supports from China’s regulatory reforms in accelerating patient access to clinically urgently needed innovative drugs. Benefiting from the integrated healthcare ecosystem of the Hainan Free Trade Port and the “Urgently Needed Imported Drugs for Clinical Use” policy, the Product initiated pilot clinical use in August 2023 at Boao Super Hospital within the Boao Lecheng International Medical Tourism Pilot Zone. Pilot usage subsequently expanded to designated medical institutions across the Guangdong–Hong Kong–Macao Greater Bay Area, Beijing-Tianjin region and other regions. In accordance with the relevant regulations of China’s real-world data application pilot project, as well as supported by the Hainan Provincial Medical Products Administration and the Administration of the Boao Lecheng International Medical Tourism Pilot Zone, the Product has accumulated real-world clinical data in China under pilot application, significantly accelerating its clinical, registration and approval timelines. The Product received its Drug Registration Certificate on January 30, 2026 (approval date: January 27, 2026).Following its approval, in less than 1.5 months (including the Chinese New Year holiday), the initial prescriptions for ruxolitinib phosphate cream have been issued across multiple regions and hospitals, reflecting the highly efficient collaboration and concerted efforts among CMS teams, regulatory authorities and business partners. With robust support from the cross-departmental coordination mechanism of the Beijing Daxing Airport Economic Zone Joint Administrative Committee, once import conditions were met, the Product completed customs clearance approval, sampling and related customs procedures within 24 hours, and obtained the drug testing report within 7 working days, representing efficient execution and acceleration for the innovative drugs in China. During this process, the Beijing Municipal Medical Products Administration proactively provided end-to-end policy guidance; the government service center has efficiently completed customs clearance filing; the Beijing Institute for Drug Control has conducted methodological pre-testing to accelerate timelines for innovative drug, and continuous worked during the Chinese Spring Festival; and Daxing Airport Customs provided specialized pre-guidance on declaration and swiftly completed customs review and release. Through parallel workflows and coordinated execution, all parties collectively pressed the “fast-forward button” for the Product’s commercialization, helping this urgently needed innovative therapy reach patients faster.As the Product enters the large-scale clinical application stage, it is expected to further strengthen Dermavon’s comprehensive dermatology solutions and brand value. Building on its leadership in skin health, Dermavon will continue to improve accessibility of ruxolitinib phosphate cream to benefit more vitiligo patients and steadfastly safeguard public skin health through innovation.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. The discolored areas usually get bigger with time and the condition could influence skin on any part of the patients’ body. Vitiligo usually affects the appearance of patients, especially on exposed areas such as the face and neck. According to a study that involved over 1,000 diagnosed vitiligo patients, over 45% of patients have facial involvement, and over 20% of patients have neck involvement[1].The obvious presence of white patches may make patients feel that their appearance has been compromised, which in turn materially affects their social life, and is associated with a significantly higher incidence of mental health disorders; accordingly, there is an urgent need for effective treatment options for vitiligo[2].It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[1]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. Ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More Information About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is the first and only drug approved for the repigmentation of non-segmental vitiligo by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)[3,4]. In the U.S., the Product is indicated for the topical treatment of nonsegmental vitiligo in adult and pediatric patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised adult and pediatric patients aged 2 years and older whose disease is not well controlled with topical prescription therapies, or when those therapies are not advisable. In Europe, ruxolitinib phosphate cream is approved for the topical treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. In China, besides vitiligo indication, the product’s NDA for the treatment of mild-to-moderate AD in adults and pediatric patients aged 2 years and older is also under regulatory review, which has been included in the Priority Review List and is expected to accelerate the Product’s AD review process for marketing approval.The Group, through the subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream (excluding territories in which exclusive rights have already been licensed), marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. China Insights Consultancy’s industrial report 2. Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739. 3. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream4. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurarCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

盈立证券一年拓展12个服务网点 全力深化「在线x线下」O2O小区金融布局

香港, 2026年3月13日 - (亚太商讯 via SeaPRwire.com) - uSMART盈立证券有限公司(下称「盈立证券」或「本公司」)欣然宣布,第九及第十间实体服务中心正式进驻大围及屯门,短短一年内,盈立证券全港服务网络已增至12间服务中心,超越全行,积极实践「在线 x 线下」(O2O)小区金融策略,巩固港资科技券商No.1^地位,进一步扩大品牌影响力。推动小区金融服务普及化屯门分行今日举行简单而隆重的开幕典礼,标志该分行正式投入服务,为本公司的发展里程写下崭新一页。盈立证券执行董事李建翰先生 (Neo) 表示:「大围及屯门分行的开业,是我们心系本地小区,持续推动小区化服务的重要战略性部署。我们不仅追求网络覆盖率,更重视与小区的连结,贯彻『以客为本』的理念,拉近与居民的距离,朝『全港无缝覆盖』的目标迈进。」(左起︰盈立证券业务拓展经理林向尊先生、盈立证券研究部执行董事黄德几先生、盈立证券执行董事兼机构业务负责人李建翰先生、盈立证券香港市场部总监黄晓霖小姐及盈立证券业务拓展总监邓永麟先生)(左起︰盈立证券业务拓展经理林向尊先生、盈立证券研究部执行董事黄德几先生、盈立证券执行董事兼机构业务负责人李建翰先生、盈立证券香港市场部总监黄晓霖小姐及盈立证券业务拓展总监邓永麟先生)全港18区服务全覆盖 为加速实现『全港最多服务中心的科技券商』的目标,盈立证券将于第二季在核心地区 ─ 启德及旺角开设分行,并积极物色商场期间限定店及参与各类展会摊位,希望透过多渠道接触不同地区客户,藉此进一步完善地区性布置,让全港18区市民皆可轻松获取专业、个性化的投资理财服务,把金融体验融入日常生活。」投资产品多元化Neo在开幕典礼上透露,盈立证券早前更取得期货交易牌照,并计划于年中正式推出相关业务。届时客户可透过uSMART平台进行期货交易,涵盖指数期货、商品期货及外汇期货等,为投资者提供更全面的投资产品,长、中、短线投资以及低、中、高预期回报俱备,满足不同客户的需求。期货业务将全面整合至现有的 uSMART APP交易平台,客户可使用同一个APP买卖美港股、期货、ETF、基金及全权委托投资产品等,即可享受多元资产配置、风险管理及财富增值服务,高效地运用资金,灵活地管理投资组合,真正实现「一站式理财.全方位布局」。推动投资教育 强化客户互动体验盈立证券对推动投资者教育亦不遗余力,定期举办不同类型的在线及线下的投资讲座,及主题活动,如葡萄酒品鉴会及鸡尾酒工作坊,深化与客户的互动与关系,提升客户黏度,增加客户忠诚度。同时,由资深股评人兼研究部执行董事黄德几先生(Dickie)亲自带领的全新财经台,将于下周一(3月16日)强势启播,每个港股交易日的早上开市及中午收市前,由专业团队为您实时剖析市场动态与投资机遇。盈立证券期望透过更紧密的互动,协助客户精进实战技巧、优化投资决策,打造更完善的学习与实践平台。扩大团队规模 配合业务高速发展,盈立证券正积极推进本地人才招募与培训,预计未来两年职位数量将增加30%,涵盖前线分行、产品设计、财富管理、合规风控及市场营运等范畴,全面扩大团队的规模及专业能力,推动业务稳健成长。 展望未来,盈立证券将持续优化交易体验,并加强线下网点与小区活动的协同效应,进一步巩固在金融科技领域的领先地位;同时结合创新科技与小区网络,为不同年龄及资历的投资者提供更便捷、更具温度的理财服务,推动本地金融生态朝普及化及智能化发展。^「港资科技券商No.1」是取自捷利金融云截至2026年2月为止连续超过一年数据, uSMART盈立证券为香港本地港资互联网券商月成交总额排行第1。关于uSMART盈立证券:盈立证券 是一间领先科技港资券商,成立于2018年,8年来凭借卓越的战略规划和创新能力,致力于将科技与金融深度融合,业务范围涵盖证券、资产管理、财富管理等领域,为全球投资者独家研发了金融证券交易平台 uSMART HK APP和 uSMART SG APP,分别由盈立证券(香港)和盈立证券(新加坡)提供服务。集团APP 支持港股、美股、A股(沪深港通)、新加坡股票、日本股票、英国股票、美股期权、ETF、基金、债券、资管、结构化票据、期货、加密货币、贵金属、黄金和外汇等多元化的投资交易服务,此外更为超高净值个人与家族、企业提供度身订制服务,打造全方位综合性资产管理解决方案。详情可浏览 https://hk.usmartglobal.com传媒查询:黄晓霖 Carrie Wong9788 4665carriewong@usmart.hk Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Guoquan Achieves Simultaneous Growth in Scale and Profitability, Core Operating Profit Increases by 48.2% in 2025

HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – 12 March 2026, Guoquan Food (Shanghai) Co., Ltd. ("Guoquan" or the "Company"; stock code: 2517.HK), a leading one-stop home meal products brand in China, announced its annual results for the year ended 31 December 2025, which have been reviewed by the Audit Committee of the Board.Adhering to the strategic positioning of "community central kitchen" in 2025, the Company successfully established a holistic instant retail store network through a multi-channel, multi-scenario omni-channel layout and the deep integration of online and offline operating models. The Company continuously delved into consumers' demand, developed and iterated a diverse suite of product portfolios, deepened refined store operation and management, and strengthened the construction of a membership ecosystem, effectively enhancing store operational efficiency and market competitiveness. Concurrently, the Company continued to deepen its industrial layout and promote the integrated closed-loop construction of "production, supply and marketing", achieving stable development throughout the year.For the year ended 31 December 2025, the Company's revenue amounted to RMB7,810.0 million, representing a year-on-year increase of 20.7%. Gross profit reached RMB1,686.6 million, a year-on-year increase of 19.0%. Net profit was RMB453.9 million, a significant year-on-year increase of 88.2%. Core operating profit (adjusted for non-recurring items such as gains or losses on fair value changes on unlisted convertible redeemable preferred shares and donations for fire rescue in Tai Po, Hong Kong) was RMB460.7 million, representing a year-on-year increase of 48.2%. Basic and diluted earnings per share were RMB0.1630, a substantial year-on-year increase of 93.8%.Continuously Strengthening Omni-channel Instant Retail: Offline Expansion and Online Engagement Drive GrowthAs of 31 December 2025, the Company's total number of stores nationwide reached 11,566, a net increase of 1,416 stores from 10,150 as at the end of 2024, covering 31 provinces, autonomous regions and municipalities. In terms of regional store layout, the Company achieved a net increase of 1,004 township-level stores in 2025. Addressing the consumption characteristics and needs of township markets, the Company developed differentiated product structures and store displays, accurately aligning with consumer demands in lower-tier markets and further enhancing township market penetration. Concurrently, the Company continued to deploy smart retail scenarios in mid-to-high-tier markets, completing the intelligent and unmanned transformation and upgrade of over 3,000 retail stores in 2025, achieving synergistic development between lower-tier and mid-to-high-tier markets.To empower franchisees, facilitate their sales growth, and further expand consumer reach while offering a more flexible shopping experience, the Company continuously provides support and guidance to franchisees in core areas such as store operations and business development. Leveraging the Company's Guoquan APP, WeChat mini-program, third-party food delivery platforms and social commerce platforms (such as Douyin), a multi-level online sales network has been established. In 2025, the Company achieved over 9.41 billion impressions on platforms through its multi-level Douyin accounts matrix. Stores generated GMV of RMB1.49 billion via the Douyin channel, representing a year-on-year increase of 75.3%.Membership Ecosystem Continuously Improved; Product Portfolio Enhances in Scenarization and RichnessIn 2025, the operation of the Guoquan membership program yielded significant results, further releasing the value of the membership ecosystem. During the Reporting Period, the number of the Company's registered members reached approximately 64.9 million, a year-on-year increase of 57.1%, demonstrating rapid expansion of the membership base. The prepaid card business also achieved stable growth, with the value stored in prepaid cards amounting to approximately RMB1.2 billion during the Reporting Period, a year-on-year increase of 22.3%. This indicates continuously improving member stickiness and consumption contribution, forging a closer connection with consumers.Relying on its substantial membership base, the Company persistently pursues innovation in its product offerings, consistently upholding the business philosophy of providing consumers with "tasty, convenient and value-for-money" products. It continuously enriches its product portfolio and iterates new products to comprehensively meet consumers' diverse dining needs. As of 31 December 2025, the Company had introduced 282 new SKUs of hot pot and barbecue products. It created multiple scenarized meal suites such as the "Barbecue Camping Container Set", "Crayfish Feast Set", and "Six Popular Hot Pot Sets", achieving deep integration of products and consumption scenarios. Furthermore, the Company expanded its product categories within the drinks and beverage consumption scenario, launching products such as NFC fruit juices, craft beer, and flavored tea beverages. This continuously enhances the richness and diversification of the product matrix, further perfecting the one-stop meal products supply system.Deepening Industrial Layout; Strengthening Digitalized Supply Chain ControlGuoquan continues to promote the integrated closed-loop construction of "production, supply and marketing". Adopting a "one-product-one-factory" strategy, it further deepens the breadth and depth of its industrial layout, providing solid production capacity support for business development. As of 31 December 2025, the Company possessed seven food ingredient production plants, covering core categories such as condiments, meatballs, paste and aquatic products, and beef products, forming a comprehensive and well-defined production capacity matrix. Concurrently, the construction of the Company's food production base in Danzhou, Hainan Province, officially commenced. This base will further expand its geographical coverage, optimize the supply chain's radiation radius, and strengthen the national production capacity layout and logistics reach.This solid industrial foundation continuously improves the operational efficiency of the digitalized supply chain. Based on the supply chain system operating from factory to central warehouse and to retail stores, the Company can monitor supply and demand dynamics from the procurement end to the store end, and closely manage inventory levels, thereby achieving efficient management of the entire supply chain. As of 31 December 2025, the Company had deployed 20 digitalized central warehouses across China, achieving swift product circulation through digital stock and barcode management. Simultaneously, the digitalization of the supply chain covering core segments such as production, procurement, warehousing, and logistics allows for precise monitoring of supply-demand dynamics and inventory levels, ensuring the timely supply of products to stores in the Chinese mainland. This comprehensively enhances the overall operational efficiency of the supply chain, solidifying core barriers in cost control and quality assurance.Six Core Strategic Directions: Continuously Advancing Business UpgradesIn 2026, Guoquan targets that the total number of stores will exceed 14,500, representing a net increase of over 2,934 stores, with an estimated store closure rate of less than 4%. It targets high-single-digit growth in store efficiency, and the number of registered members is targeted to exceed 95 million. The Company targets that the growth rate of core operating profit will be significantly higher than that of its revenue.First, Fully expand the sales network with four stores jointly advancing with concerted efforts. Guoquan will continue to build a multi-level sales network, accelerate the expansion of large stores in townships, practice the philosophy of "food equality", and precisely meet the consumption needs of residents in county and township markets. Concurrently, it will explore innovative store formats and upgrade the franchisee management system to build a symbiotic and mutually beneficial franchise ecosystem.Second, Deepen the strategy of community central kitchen to expand community consumption scenarios. The Company will focus on creating food retail solutions for "four meals a day", continuously diversifying its product categories and building a more competitive product matrix to achieve organic sales growth while further consolidating its advantages in lower-tier market layout.Third, Deepen membership operation and IP to advance the community brand project. The Company will continue to advance refined membership operation, deeply integrate media resources such as popular TV commercials, offline community advertising and social media and e-commerce platforms (such as Douyin) to expand its membership base, and improve the membership rights system to enhance member loyalty and stickiness. Furthermore, it will further deepen the operation of its brand IP image "Guobao" to strengthen brand value and emotional resonance with consumers.Fourth, AI big data empower stores to innovate smart retail scenarios. By integrating Internet of Things, big data, and AI technology, the Company will drive the smart operation of stores with data. It will promote the in-depth integration of the Guoquan stir-fry business format with smart cooking machines, accurately analyze consumers' dining habits, optimize dish parameters and cooking procedures for smart cooking machines, realize the standardized production of stir-fry dishes, and optimize the consumer experience.Fifth, Continue to promote the industrial layout and strengthen the advantage of one-product-one-factory. Adhering to the "one-product-one-factory" strategy, Guoquan will further integrate upstream resources domestically and internationally, accelerate the construction of the food production base in Danzhou, Hainan Province, increase R&D investment, and launch more product portfolios with a high quality-price ratio.Sixth, Develop overseas markets in phases to deliver the good taste of China. Guoquan plans to explore and establish a presence in overseas regional markets in a phased manner to unlock long-term growth potential. Leveraging its core competitiveness, it will steadily advance its overseas market exploration. It also plans to take the lead in opening stores in Hong Kong Special Administrative Region, China to accumulate and gather operational experience, gradually achieving overseas product sales and enhancing global brand visibility.About Guoquan Food (Shanghai) CO., LTD. (2517.HK):Guoquan Food (Shanghai) Co., Ltd. (“Guoquan”; Stock Code: 2517.HK) is the leading one-stop home meal products brand in China, offering a variety of ready-to-eat, ready-to-heat, ready-to-cook and prepared ingredients, with a focus on at-home hotpot and barbecue products.  Leveraging Company’s robust supply chain capabilities, a strategic industrial layout with self-owned factories, a nationwide network of around 10,000 instant retail stores, and a carefully curated product portfolio, Company offer a variety of home meal products solution under the “Guoquan Shihui” brand, catering to different dining scenarios.This press release is issued by EverBloom (HK) Communications Consultants Group Limited on behalf of Guoquan Food (Shanghai) Co., Ltd. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

康哲药业:磷酸芦可替尼乳膏(百卢妥(R))在中国多地实现白癜风首批处方落地

深圳, 2026年3月13日 - (亚太商讯 via SeaPRwire.com) - 2026年3月12日,康哲药业控股有限公司 ("康哲药业")欣然宣布,旗下德镁医药有限公司("德镁医药",专业聚焦皮肤健康的创新型医药企业,正申请于香港联合交易所有限公司主板独立上市),其创新处方药磷酸芦可替尼乳膏(百卢妥(R))("产品",在美国、欧洲及加拿大以Opzelura(R)的名称销售)在全国30个省级行政区为白癜风患者开出首批处方,覆盖包括复旦大学附属华山医院、上海市皮肤病医院、南方医科大学皮肤病医院、成都市第二人民医院、吉林大学白求恩第一医院、中南大学湘雅二医院、和睦家医疗集团等千家在皮肤健康及疾病管理领域具有影响力的公立及私立医疗机构*,并实现超1,300家线下药店以及京东电商平台同步可及。*医院排名不分先后磷酸芦可替尼乳膏为中国批准的首款用于白癜风治疗的外用JAK抑制剂,今日正式拉开产品规模化临床应用的序幕,标志着我国白癜风治疗领域实现突破性进展,迈入精准靶向治疗的全新时代,产品将以经过临床充分验证的安全和有效性,点亮千万白癜风患者复色希望。磷酸芦可替尼乳膏的跨越式商业化进程,不仅彰显了康哲药业卓越的产品运营能力,更充分体现了国家药政改革对临床亟需创新药加速可及的有力支持。受益于海南自贸港医疗健康产业整合性优势,以及 "临床急需进口" 政策,2023年8月,产品率先在海南博鳌乐城国际医疗旅游先行区博鳌超级医院启动临床应用,随后试点应用逐步扩展至粤港澳大湾区、京津等区域指定医疗机构。在我国药品真实世界数据应用试点有关程序,以及海南省药品监督管理局与海南博鳌乐城国际医疗旅游先行区管理局的支持下,产品通过"先行先试"临床应用积累中国真实环境的诊疗数据,大大提速产品临床、注册和获批上市进程,并成功于2026年1月30日取得《药品注册证书》(批准日期2026年1月27日)。获批以来,仅耗时不到1.5个月(含春节假期),磷酸芦可替尼乳膏便实现全国多地、多医院首批处方集中落地,这亦是康哲药业各部门、相关监管部门及合作伙伴高效联动、共同努力的成果。在北京大兴临空区联合管委会跨部门合作机制的有力保障下,产品具备进口条件后24小时内即完成了药品通关审批、药品抽样及海关程序,并于7个工作日内取得药品检验报告,全程跑出了高效务实的"中国创新药加速度"。在此过程中,北京市药监局主动开展商业规模批次政策的全流程指导,政务中心高效完成通关备案;北京市药品检验研究院则通过前置方法学预检验、开辟创新药专项通道,并在春节期间持续作业,全力确保检验进度高效推进;大兴机场海关则提前对药品申报要素进行专项指导,快速完成报关审核和药品放行工作。各方协同、流程并联,合力为磷酸芦可替尼乳膏上市按下"快进键",助力该临床急需创新药惠及广大患者。随着产品进入规模化临床应用阶段,将进一步强化德镁医药皮肤疾病综合解决方案及品牌价值。德镁医药依托在皮肤健康领域的领先地位,将持续推进磷酸芦可替尼乳膏使更多白癜风患者获益,以创新之力坚定守护民众皮肤健康。关于白癜风白癜风是一种慢性自身免疫性疾病,其特征是皮肤色素脱失,其发病原因为产生色素的细胞即黑素细胞的缺失。脱色区域通常会随着时间的推移而扩大,且该病症可能影响患者身体任何部位的皮肤,影响患者的容貌,尤其是面部、颈部等显眼部位。根据一项对1,000多名已确诊白癜风患者进行的研究,超过45%的患者面部受累,超过20%的患者颈部受累[1]。白色斑块的明显存在可能会让患者认为自身的形象受到损害,进而严重影响其社会活动,精神疾病发病率显著增加,因此白癜风的治疗需求非常迫切[2]。据估算,中国约有1,030万人患有白癜风,其中约820万人患有非节段型白癜风[1]。现有疗法,如外用糖皮质激素(TCS)及外用钙调神经磷酸酶抑制剂(TCIs)存在临床缺陷,长期用药有不良反应或疗效有限。磷酸芦可替尼乳膏成功填补了白癜风靶向药物治疗的空白,具有重大标志性意义。关于磷酸芦可替尼乳膏的更多信息磷酸芦可替尼乳膏(Opzelura(R))是Incyte开发的选择性JAK1/JAK2抑制剂芦可替尼制成的一种创新型乳膏,是经美国食品药品监督管理局(FDA)及欧洲药品管理局(EMA)批准的首款也是唯一一款用于非节段型白癜风复色的药物[3,4]。在美国,产品获批用于局部治疗成人及12岁及以上儿童患者的非节段型白癜风;及其他外用药控制不佳或不建议使用时,非免疫功能受损的2岁及以上儿童和成人轻中度特应性皮炎的局部短期和非持续性慢性治疗。在欧洲,磷酸芦可替尼乳膏被批准用于局部治疗成人及12岁及以上青少年伴面部受累的非节段型白癜风。在中国,除白癜风适应症外,产品2岁及以上儿童和成人轻中度特应性皮炎(AD)适应症亦处于NDA审评阶段, 且该项NDA已获纳入优先审评品种名单,有望加快产品AD适应症上市审评进程。康哲药业于2022年12月2日,通过德镁医药的附属公司与Incyte就磷酸芦可替尼乳膏订立合作和许可协议("许可协议"),获得在中国大陆、香港特别行政区、澳门特别行政区、台湾地区及东南亚十一国("区域")研发、注册及商业化产品的独家许可权利,以及在区域内生产产品的非独家许可权利。德镁医药的附属公司已将磷酸芦可替尼乳膏除中国大陆外的其他区域的相关权利再许可予康哲药业(不包括德镁医药及其附属公司)。Incyte拥有磷酸芦可替尼乳膏全球开发和商业化权利(已独占许可区域除外),在美国及欧洲以Opzelura(R)的名称销售。Opzelura(R)和Opzelura(R)标识是Incyte的注册商标。关于康哲药业康哲药业是一家链接医药创新与商业化,把控产品全生命周期管理的开放式平台型企业,致力于提供有竞争力的产品和服务,满足尚未满足的医疗需求。康哲药业专注于全球首创(FIC)及同类最优(BIC)的创新产品,并高效推进创新产品临床研究开发和商业化进程,赋能科研成果向诊疗实践的持续转化,造福患者。康哲药业聚焦专科领域,拥有被验证的商业化能力,广泛的渠道覆盖和多疾病领域专家资源,核心在售产品已获领先的学术与市场地位。康哲药业围绕优势专科领域不断纵深发展,以巩固心肾代谢/消化/眼科/皮肤健康业务竞争力,带来专科规模效率,其中皮肤健康业务(德镁医药)已成为其细分领域的龙头企业,并拟于联交所独立上市。同时,康哲药业持续推动研产销全产业链在东南亚及中东区域运营发展,以获取新兴市场的增量,助力集团实现高质量可持续发展。参考文献/资料1.数据来自灼识咨询报告2.Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739.3.FDA批准信息可在Incyte官网查询,网址:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream4.EMA批准信息可在Incyte官网查询,网址:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广,非广告用途。本新闻不对任何药品和医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息,请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请,不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制,但康哲药业并无进行任何说明或保证、明述或暗示,或其他表述,对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述,该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证,存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测,康哲药业对该等第三方声明及预测不承担责任。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Revenue Triples in Four Years! Qunabox Group Reports RMB290 Million in Net Profit in 2025

HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – Against the dual boost of a global technological revolution and China’s policies to expand domestic demand, the integration of AI with consumption scenarios has entered a phase of accelerated development. As a leading enterprise in China’s AI interactive marketing services sector, Qunabox Group (00917.HK) has seized industry opportunities and continued to deepen its core strategy of “AI + Consumption Scenarios”. The Company has achieved breakthroughs across multiple dimensions, including technological research and development, business deployment and global expansion, demonstrating strong development resilience and growth potential.On 12 March, Qunabox Group announced its 2025 financial results. According to the data, the Company maintained a robust growth momentum during the year, recording revenue of RMB1.663 billion, a year-on-year increase of 24.2%. More notably, the Company’s profitability continued to strengthen, with profit for the period reaching RMB290 million. The Company successfully turned losses into profits, marking the beginning of a new stage of development.The accounting loss recorded by Qunabox Group in 2024 was mainly attributable to changes in the fair value of preferred shares during the listing period. With the elimination of these accounting-related disturbances, the Company’s genuine intrinsic profitability has become increasingly evident, signaling that Qunabox has officially entered a golden period of growth driven by the explosive release of scale effects.Building a Solid Technological Foundation and Driving Qualitative Performance Growth Through Product InnovationIn 2025, Qunabox Group continued to deepen its “AI + Consumption Scenarios” strategy by increasing investment in underlying technologies and platform capabilities. R&D expenses rose significantly by 75% year-on-year, laying a solid technological foundation for the Company’s development. By building a unified AI technology middle platform and a modular capability system, the Group achieved improvements in both R&D efficiency and technology reusability.Its self-developed AI-OMNI multimodal neural integrated collaboration engine achieved key breakthroughs in perception, decision-making, and execution, becoming the core technological support for the Group’s product innovation. Leveraging these technological advantages, Qunabox Group systematically launched and upgraded a series of AI-powered interactive marketing products, including AI digital human shopping assistants, AI holographic marketing cabinets, an AIGC middle platform and resource library, AI Agent workstations, and AI data and strategy analytics solutions. These innovations provide reliable support for implementation across multiple businesses and scenarios, directly driving high-quality revenue growth.Business Synergy Fueling Expansion, Global Layout Unlocking New Growth PotentialBy business segment, the marketing services segment, the Group’s core business, recorded a year-on-year revenue increase of 27.8% in 2025 to reach RMB1.402 billion. Among them, the high-margin value-added marketing services delivered a standout performance, with revenue hitting RMB236 million, a year-on-year surge of 32.9%. Its revenue share continued to rise, driving the optimization of the overall revenue quality and gross margin structure. In 2025, the gross profit of this segment amounted to RMB875 million, up 28.8% year on year.As the strategic practice platform for the Group's "AI experiential consumption" initiative, the merchandise sales segment achieved continuous improvements in the commercial conversion efficiency of AI interactive terminals. This was accomplished through expanding the terminal network in high-potential cities such as Hangzhou, Chengdu and Ningbo, optimizing the product portfolio toward higher-margin items, and replacing traditional price promotions with intelligent interactive marketing. The segment has developed strong synergies with the core marketing services and become an important scenario for the commercial application of cutting-edge technologies. In 2025, revenue from the merchandise sales segment of Qunabox Group increased by 5.2% year on year to RMB194 million, while gross profit rose by 12.7% year on year to RMB49 million.The layout of lifestyle and innovative businesses has unlocked a new dimension of global growth for Qunabox Group. In 2025, focusing on "AI + Lifestyle", the Group expanded into the Middle East, Southeast Asia and Australia simultaneously. An overseas business department was established to oversee the full implementation of global operations, and strategic cooperation has been reached with key local partners in Dubai. Currently, Qunabox Group has completed the preliminary preparations for its AI-powered indoor entertainment spaces and obtained operating licenses in Dubai and Singapore. The establishment of overseas teams, product localization and refinement, as well as the integration of software and hardware systems are advancing steadily. The Group has also completed the validation of localized AI models, ensuring that its AI-driven interactive experiences can be accurately adapted to multilingual and cross-cultural scenarios. This lays a solid foundation for the scalable expansion of its overseas business, which is expected to become the Company’s second growth curve for performance.Expanding Customer Base: A New Journey for AI + Consumption ScenariosLeveraging its innovative and efficient business model and outstanding service capabilities, Qunabox Group has maintained sound and stable partnerships with brand clients. Additionally, the Company has expanded the application scenarios of its services, enriched and optimized its AI-driven interactive marketing products, developed data strategy solutions, and refined its marketing product portfolio and service model. As a result, the Company has continuously expanded its industry influence, deepened cooperation with high-quality clients, and steadily grown its premium client base, with both the number of brand clients and key accounts on the rise. In 2025, the total number of brand clients served by Qunabox Group increased to 332 for the full year, including 58 key accounts. The average revenue per key account grew by 15% year on year, reflecting a continuous rise in client value and further consolidating the foundation for the Company’s sustained performance growth.Supported by strong performance, Qunabox Group maintained a sound financial position and ample cash flow throughout the year. As at 31 December 2025, the Group’s cash and bank balances amounted to RMB1.506 billion, providing strong support for subsequent investments in technology, business expansion and global deployment.In summary, Qunabox Group’s outstanding performance in 2025 is the inevitable result of its years of deep engagement in AI technologies and its steadfast implementation of the “AI + Consumption Scenarios” strategy. The turnaround from loss to profit further demonstrates the sustainability of its business model and the growth potential of its profitability.Looking ahead, as the integration of artificial intelligence with physical consumption scenarios continues to deepen, a window of opportunity has emerged for the large-scale deployment of AI applications. With technology at its core and scenarios as its foundation, Qunabox Group is building a cross-regional, end-to-end AI lifestyle platform. Amid the accelerated cultivation of new quality productive forces, the Company, leveraging its technological barriers, scenario advantages and global vision, is well positioned to continue leading the industry transformation in the integration of AI and consumption and to achieve long-term sustainable development of its own. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Spritzer Sparkling’s ‘Serikan Raya, Sparkling-kan Suasana’ Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist

From a joyful Raya musical to new and improved festive recipes, Spritzer Sparkling inspires Malaysians to embrace fresh new ideas alongside tradition to elevate their Raya celebrationsSpritzer Sparkling’s 2026 Raya musical brand film “Samting-Samting”, stars Fimie Don and Wani Kayrie as a married couple, and Elliza Razak as Mak Ngah.TAIPING, Malaysia, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities. As families balik kampung and fill their homes with the joy and warmth of festive cooking this year, Spritzer Sparkling invites Malaysians to celebrate Raya with a modern twist through its ‘Serikan Raya, Sparkling-kan Suasana’ campaign, showcasing the versatility of the product in boosting the creativity and flair of beloved Raya dishes.For the first time, Spritzer Sparkling is expanding beyond its well-loved role as a beverage mixer with a fresh take on festive cooking through the multipurpose use of its naturally refreshing sparkling water in your favourite recipes. Spritzer Sparkling transforms five traditional must-have Raya dishes into festive showstoppers, bringing a new dimension of taste with its lively carbonation enhancing the texture, crispiness, and tenderness of the dishes. These favourites include Cucur Udang Crispy, Rendang Tok Melting, and Roti Jala with Kari Ayam, alongside refreshing drinks like Bunga Longan Sparkling and Limau Selasih Pudina Sparkling.This Raya, add a little ‘Samting-Samting’ extra to your recipes for an exciting new twist on your favourite festive dishes with Spritzer SparklingEach recipe showcases how the natural bubbles from Spritzer Sparkling help create lighter, crispier batters for a satisfying crunch and more tender, flavourful meats without changing the essence of the dishes. Whether it is giving your cucur udang a delightful crisp or tenderising your rendang meat and shortening the braising time, Spritzer Sparkling makes these traditional favourites even more enjoyable in simple, effortless ways.Shiao Chan, Head of Marketing at Spritzer, said, “Hari Raya Aidilfitri is a celebration deeply rooted in family traditions where food plays a central role in bringing people together. Through ‘Serikan Raya, Sparkling-kan Suasana’, we wanted to show Malaysians that tradition and heritage can co-exist and even be preserved through innovation and new perspectives. Spritzer Sparkling is not just a refreshing beverage for every season, but also a multi-faceted ingredient that can enhance festive dishes and drinks, creating memorable family moments in the kitchen and around the dining table.”A Musical Aidilfitri AwaitsBringing the Raya story to life is Spritzer’s musical film titled ‘Samting-Samting’, starring Fimie Don, Wani Kayrie and Elliza Razak. As the official Spritzer Sparkling brand ambassadors for Raya 2026, Fimie Don and Wani Kayrie, play a modern newlywed couple returning to the husband’s kampung for their first Raya together in the film that blends comedy, drama and music in an irresistibly Malaysian narrative.The young wife, Alia, takes on the kitchen with confidence, using her own modern approach to classic family dishes, prepared using her secret ingredient: Spritzer Sparkling. Mak Ngah, the family’s long-standing culinary matriarch, feels her role is being challenged and grows increasingly suspicious about Alia’s unusually delicious cooking, suspecting “Samting-Samting” is amiss. The story humorously unravels the “secret” behind Alia’s crowd-pleasing flavours, capturing family dynamics and celebrating new perspectives, shared discovery, and the warmth of intergenerational bonding.Home-cooks excited to try this new twist to classic recipes can check out the recipes for the featured dishes and beverages using Spritzer Sparkling as a game-changing ingredient on Spritzer’s Raya microsite here.Spritzer’s 2026 Raya campaign celebrates family traditions, playful generational dynamics in the kitchen, and creative festive cooking with Spritzer Sparkling.Also available on the website are the musical film, promotional details, meet-and-greet information with Fimie Don and Wani Kayrie, as well as gift-with-purchase promotions available at participating outlets nationwide.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottleFor more information, visit www.spritzer.com.myFor media inquiries please contact:Farah ShahrulAssociate Consultant, Narro CommunicationsE: farah@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my        Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

规模与效益双升 锅圈2025年核心经营利润增48.2%

香港, 2026年3月13日 - (亚太商讯 via SeaPRwire.com) - 中国领先的一站式在家吃饭餐食产品品牌锅圈食品(上海)股份有限公司(简称"锅圈"或"公司",股票代号:2517.HK)公布截至2025年12月31日止十二个月经董事会审核委员会审阅之全年业绩。2025年,锅圈坚持"社区央厨"的战略定位,通过多渠道、多场景的全域布局,深度融合线上线下运营模式,成功构建全方位的即时零售门店网络。公司持续深耕消费者需求,不断开发并迭代多样化套餐产品组合,深化门店精细化运营管理,健全会员生态体系建设,有效提升了门店经营效能与市场竞争力。与此同时,公司持续深化产业端布局,推动"产供销"一体化闭环建设,实现全年稳健发展。截至2025年12月31日止年度,锅圈收入为人民币7,810.0百万元,同比增长20.7%;毛利为人民币1,686.6百万元,同比增长19.0%;净利润为人民币453.9百万元,同比增长88.2%;核心经营利润(经调整后非上市可转换可赎回优先股公允价值变动损益、香港大埔火灾救援捐赠等一次性因素后)为人民币460.7百万元,同比增长48.2%;每股基本及摊薄盈利为人民币0.1630元,同比增长93.8%。持续夯实全渠道即时零售 线下扩张+线上联动驱动增长截至2025年12月31日,锅圈全国门店总数达11,566家,较2024年末的10,150家净增1,416家,全面覆盖全国31个省、自治区及直辖市。在门店区域布局上,2025年公司净新增1,004家乡镇门店,并针对乡镇市场消费特点与需求,打造差异化产品结构与门店陈列,实现与下沉市场消费需求的精准匹配,进一步提升乡镇市场渗透率。与此同时,公司持续布局中高线市场智能化零售场景,2025年完成超三千家零售门店的智能化、无人化改造升级,实现下沉市场与中高线市场的协同发展。为赋能加盟商、促进其销售增长,并进一步扩大消费者覆盖范围、提供更灵活的购物体验,公司持续在门店运营、业务发展等核心环节为加盟商提供支持,依托锅圈APP、微信小程序、第三方外卖平台及社交商务平台(如抖音),构建多层次的线上销售网络。2025年,公司通过多层级抖音账号矩阵实现超94.1亿次平台曝光量,门店通过抖音渠道实现GMV达14.9亿元,同比增长75.3%。会员生态体系持续完善 产品矩阵场景化与丰富度双提升2025年,锅圈会员计划运营成效显著,会员生态体系价值进一步释放。于报告期内,公司注册会员数量达约6,490万名,同比增长57.1%,会员规模实现快速扩张;预付卡业务同步实现稳健增长,报告期内预付卡预存金额达约人民币12.0亿元,同比上升22.3%,会员黏性与消费贡献持续提升,与消费者的连结更为紧密。以庞大的会员基础为依托,公司持续深耕产品端创新,始终秉持"好吃方便还不贵"的经营理念,不断丰富产品组合并迭代新品,全方位满足消费者多样化用餐需求。截至2025年12月31日,公司共推出282个火锅及烧烤类产品的新SKU,打造"烧烤露营集装箱套餐""小龙虾畅享套餐""六大国民火锅套餐"等多款场景化套餐产品,实现产品与消费场景的深度融合。此外,公司围绕酒水饮料消费场景进行品类拓展,推出NFC果汁、精酿啤酒、风味茶饮等产品,持续提升产品矩阵的丰富度与多元化程度,进一步完善一站式餐食产品供给体系。深化产业端布局 强化供应链数字化管控锅圈持续推动"产供销"一体化闭环建设,通过"单品单厂"策略进一步深化产业端布局的深度与广度,为业务发展提供坚实的产能支撑。截至2025年12月31日,公司已拥有7个食材生产厂,覆盖调味料、丸滑水产、牛肉等核心品类,形成品类齐全、分工明确的产能矩阵;与此同时,公司位于海南省儋州市的食品生产基地正式动工建设,未来将进一步拓宽地理覆盖范围,优化供应链辐射半径,强化全国产能布局与物流辐射能力。产业端的坚实基础推动供应链数字化运营效率持续提升,基于从工厂到中央仓再到零售门店的供应链体系,公司能对从采购端到门店端的供需动态进行监控,并密切把控存货水平,从而实现对整个供应链的高效管理。截至2025年12月31日,公司已布局20个数字化中央仓库,透过数字化存货和条码管理实现产品快速流通;与此同时,实现生产、采购、仓储、物流等核心环节的供应链数字化,精准监控供需动态与存货水平,保障中国内地门店产品及时供应,全面提升供应链整体运营效率,筑牢成本管控与品质把控的核心壁垒。六大核心战略方向 持续推进业务升级2026年,锅圈预计门店总数超过14,500家,即净新增门店超2,934家,预计关店率低于4%,门店店效实现高单位数增长,注册会员数量超过95百万名。公司预计核心经营利润增速将明显高于收入增速。一是,全面拓展销售网络,四店齐发聚力共进。锅圈将继续打造多层级销售网络,加速乡镇大店拓展步伐,践行"美食平权"理念,精准对接县乡市场居民的消费需求;与此同时,探索创新店型且升级加盟商管理体系,构建共生共赢的加盟生态。二是,深化社区央厨战略,延展社区消费场景。公司将围绕"一日四餐"打造餐饮零售解决方案,持续布局多元品类,打造更具市场竞争力的产品矩阵,实现销售规模的有机增长的同时,进一步夯实下沉市场布局优势。三是,深耕会员运营及IP,推进社区品牌工程。公司将持续推进会员精细化运营,深度整合知名电视广告、线下社区广告和社交电商平台(如抖音)等媒体资源,扩大会员规模,并完善会员权益体系,提升会员忠诚度与黏性。与此同时,公司将进一步深化品牌IP形象"锅宝"的运营,提升品牌价值与消费者的情感连结。四是,AI大数据赋能门店,创新智慧零售场景。结合物联网、大数据及AI技术实现门店智能化运营,推动锅圈小炒与智能炒菜机深度融合,精准分析消费者餐饮习惯,优化智能炒菜机的菜品参数与烹饪流程,实现菜品标准化制作并优化消费体验。五是,持续推动产业布局,强化单品单厂优势。锅圈坚守"单品单厂"策略,将进一步整合海内外上游资源,加快海南省儋州市食品生产基地建设,加大研发投入并推出更多高性价比产品组合。六是,海外市场分阶落地,传递中国好味道。锅圈计划分阶段布局海外市场,挖掘长期增长潜力,立足核心竞争力稳步推进海外市场探索,亦计划率先在中国香港开设门店并积累运营经验,逐步实现产品海外销售,提升全球品牌知名度。關於鍋圈食品(上海)股份有限公司(2517.HK):鍋圈食品(上海)股份有限公司(股票代號:2517.HK)是中國領先的一站式在家吃飯餐食產品品牌,提供即食、即熱、即煮和即配食材,並專注於在家火鍋和燒烤產品。憑藉強大的供應鏈能力、自有工廠的產業端佈局,遍佈全國的萬家即时零售門店網絡及精心策劃的產品組合,公司使用「鍋圈食匯」品牌為消費者提供各種在家吃飯餐食產品解决方案,服務於不同的用餐場景。本新聞稿由九富(香港)財訊公關集團有限公司代表鍋圈發佈。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Founders Metals Upgrades Lower Antino to Advanced Target; Hits 65.9 m of 1.16 g/t Gold

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 12, 2026) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces that Lower Antino has been upgraded from Intermediate to Advanced Target status - the same internal classification* as Upper Antino - at its Antino Gold Project in southeastern Suriname (Figure 1). The upgrade follows cumulative drilling of 50 diamond drill holes including eight new holes reported here that continue to demonstrate broad, continuous gold mineralization, highlighted by 65.9 metres (m) of 1.16 grams per tonne (g/t) gold (Au) within a broader envelope of 115.0 m of 0.83 g/t Au from surface in drill hole LA046.HighlightsLower Antino upgraded to Advanced Target status with 50 drill holes released to date with an additional 10 holes pending assays and further expansion drilling underwayBest intercept to date: 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au from surface (LA046)Broad mineralized envelopes confirmed: 113.5 m of 0.34 g/t Au from surface including 30.0 m of 0.82 g/t Au (LA044)Intrusion-hosted gold mineralization intersected in all eight drill holes reported in this release; mineralization remains open along strike and at depthColin Padget, President & CEO, commented, "Lower Antino's upgrade from Intermediate to an Advanced Target - now sharing the same classification as Upper Antino - reflects consistent, broad gold mineralization across a growing number of drill holes. LA046 returning 65.9 metres of 1.16 g/t gold within a 115-metre mineralized envelope is the best intercept to date at this target and underscores the scale and continuity of the Lower Antino intrusion-hosted gold system. With gold in every hole and consistently wide intercepts, Lower Antino is emerging as a meaningful contributor to the district's overall potential. While our focus remains on exploration and expansion drilling, Lower Antino's advancement to the same classification as Upper Antino means it is expected to be considered for inclusion in any future resource estimate for the district."Lower Antino - Upgraded to Advanced TargetThe Company reports assay results from eight diamond drill holes (LA043 to LA050) at the Lower Antino target, located approximately 3.5 km east of the Upper Antino deposit (Figure 1). All eight holes intersected gold mineralization, with results highlighted by 65.9 m of 1.16 g/t Au within 115.0 m of 0.83 g/t Au in LA046 (Table 1). The 115-metre intercept in LA046 begins at surface and represents an up-dip expansion of the previously released 90.0 m of 1.02 g/t Au in LA041, confirming the continuity and growth potential of the mineralized zone.Based on cumulative drilling results, Founders has upgraded Lower Antino from Intermediate Target to Advanced Target status, ranking it on the same tier as Upper Antino in terms of overall target quality and scale potential. The upgrade reflects the demonstrated continuity of gold mineralization across numerous drill sections and identification of multiple parallel, northeast-trending mineralized zones over approximately 1.9 km of drill-defined strike length within a broader 1.5 km by 2.8 km gold-in-auger anomaly.The target is open along strike and at depth with drilling ongoing to the south and southeast at regular 100 to 200 metre steps. Overall, gold mineralization remains consistent with previous Lower Antino drill results and is hosted in intensely sericite-altered, sheared tonalite with disseminated pyrite and quartz-pyrite veining. The southernmost hole in this release (LA050), intersected 24.0 m of 0.57 g/t Au and represents approximately 200 metres of southward expansion of the mineralized system. Assay results are presented in Table 1, with drill hole locations in Table 2.Lower Antino is one of two Advanced Targets within Founders' 102,360-hectare contiguous land package, which hosts eight drill tested gold targets across the 55 km long Antino concession. The upgrade of Lower Antino adds meaningful scale to the Company's growing inventory of drill-defined gold mineralization at the district level. The Company will continue to systematically advance and upgrade high-quality targets as defined by geological criteria linked to scale and growth potential.*The Company's internal target classification system reflects drill density, demonstrated continuity of mineralization, and data sufficiency; it does not correspond to NI 43-101 resource categories.Figure 1: Antino Gold Project Property MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_001full.jpgFigure 2: Lower Antino Plan MapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_002full.jpgFigure 3: Lower Antino cross-section through central gold trend.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/7574/288304_571962fb64ca9a3d_003full.jpgTable 1: Lower Antino Drill ResultsDrillholeFrom (m)To (m)Interval (m)Au (g/t)Results from This ReleaseLA043162.00174.0012.001.56incl.167.00174.007.002.56LA0441.50115.00113.500.34incl.8.1038.1030.000.82LA0450.0020.1020.100.31and111.00124.0013.000.44LA0460.00115.00115.000.83incl.41.10107.0065.901.16LA0470.008.108.100.94and149.00156.007.000.46LA0480.0027.6027.600.22and173.00178.005.000.80LA0496.6011.104.500.21LA05047.1071.1024.000.57Previously Released Highlight ResultsLA041156.00246.0090.001.02incl.176.00178.002.0028.44LA00374.10156.0081.901.00incl.106.00132.0026.002.36LA0250.00241.00241.000.27incl.0.0086.1086.100.43LA03329.1060.0030.901.56LA02472.00122.0050.001.02LA028108.00163.0055.000.64incl.110.00117.007.002.32LA0190.0065.0065.000.49incl.44.1065.0020.901.11LA01033.6057.6024.001.23 **Intervals are down-hole depths. True widths of mineralization are estimated to be approximately 85% of the down-hole interval based on currently available results and observations. All are diamond drill holes. Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts. Composites are calculated using a 0.10 g/t Au cut-off grade with <5.0 m of internal dilution of zero grade and a minimum composite length of 2.0 m. <0.2 g/t Au intercept are not included.Table 2: Lower Antino Drill Hole Locations from This ReleaseDrillholeEasting (m)Northing (m)Elevation (m)Azimuth (°)Dip (°)Depth (m)LA043821605.33401160.67176.46269.80-50.20212.14LA044821488.00401166.00177.47270.20-50.10206.00LA045821484.00401462.00125.22270.20-50.20302.00LA046821456.00401365.00152.33270.00-50.00200.14LA047821535.00401794.67127.95270.10-50.20263.11LA048821510.00401683.00147.21269.80-50.40287.00LA049821606.67401064.33174.81270.20-50.20320.00LA050821494.33401065.67176.94270.20-50.10212.00 *The coordinate reference system is WGS 84, UTM zone 21N (EPSG 32621)About Founders Metals Inc.Founders Metals Inc. is a Canadian gold exploration company building a district-scale gold camp in southeastern Suriname. The Company controls a 102,360-hectare contiguous land package in the Guiana Shield - the largest uninterrupted package of highly prospective greenstone belt geology in the region. Founders is backed by strategic partnerships with Gold Fields and B2Gold and is executing one of the most active exploration programs in the global junior gold sector. The Company is committed to responsible exploration, strong community engagement, and disciplined capital allocation as it advances Suriname's next major gold camp.ON BEHALF OF THE BOARD OF DIRECTORS,Per: "Colin Padget"Colin PadgetPresident, Chief Executive Officer, and DirectorContact InformationKatie MacKenzie, Vice President, Corporate DevelopmentTel: +1 306 537 8903 | katiem@fdrmetals.comCautionary Statement Regarding Forward-Looking InformationThis press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, including statements regarding long term value creation and the Company's prospects. Forward-looking information can generally be identified by words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes", or variations indicating that certain actions, events or results "may", "could", "would", "might" or "will" occur or be achieved.Forward-looking statements are based on management's current expectations and reasonable assumptions but are subject to business, market, and economic risks, uncertainties, and contingencies that may cause actual results to differ materially from those expressed or implied, including: general business and economic uncertainties; exploration results; mining industry risks; and other factors described in the Company's most recent annual management discussion and analysis. Although the Company has attempted to identify important factors that could cause actual results to differ materially, other factors may cause results not to be as anticipated. There can be no assurance that forward-looking information will prove accurate, as actual results and future events could differ materially from those anticipated. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.All material information on Founders Metals can be found at www.sedarplus.ca.Quality Assurance and ControlSamples were analyzed at FILAB Suriname, a Bureau Veritas Certified Laboratory in Paramaribo, Suriname (a commercial certified laboratory under ISO 9001:2015). Samples are crushed to 75% passing 2.35 mm screen, riffle split (700 g) and pulverized to 85% passing 88 µm. Samples were analyzed using a 50 g fire assay (50 g aliquot) with an Atomic Absorption (AA) finish. For samples that return assay values over 5.0 grams per tonne (g/t), another cut was taken from the original pulp and fire assayed with a gravimetric finish. Founders Metals inserts blanks and certified reference standards in the sample sequence for quality control. External QA-QC checks are performed at ALS Global Laboratories (Geochemistry Division) in Lima, Peru (an ISO/IEC 17025:2017 accredited facility). A secure chain of custody is maintained in transporting and storing of all samples. Drill intervals with visible gold are assayed using metallic screening. Rock chip samples from outcrop/bedrock are selective by nature and may not be representative of the mineralization hosted on the project.Qualified PersonsThe technical content of this news release has been reviewed and approved by Michael Dufresne, M.Sc., P.Geol., P.Geo., an independent qualified person as defined by National Instrument 43-101.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288304 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share

Results Highlights:Revenue increased by 10.0% year-on-year to a record high of US$180.5 million, marking the fifth consecutive year of record-setting revenue performance.Sales volume hit a new high of 2.02 million units, representing a year-on-year increase of 16.2%.Gross profit rose by 7.0% to a record of US$122.4 million; profit attributable to owners of the Company rose by 5.5% to US$41.9 million.The Board has proposed a final cash dividend of HK12 cents per share, bringing the total cash dividend for the Year to HK27 cents per share alongside special dividend, representing a payout ratio of 68.4%.The Group remains in a robust financial position, with cash and bank balances of US$228.7 million at the end of the year for supporting potential acquisitions and the construction of new production facilities.Maintained revenue growth in major markets, with the Asia-Pacific market at 15.7%, the EMEA markets at 19.6%, and the US market at 37.0%.The Group actively leverages its sales network and expertise to assist high-quality medical device peers in selling their products globally, while diversifying its own product portfolio. One of the collaborative products has already been launched in Hong Kong, Malaysia, Germany, and Spain, and is progressively being rolled out to more markets in the APAC and EMEA regions.HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, today announced its annual results for the year ended December 31, 2025 (“FY2025” or the “Year”). Despite significant external challenges, the Group demonstrated remarkable resilience, achieving historic highs in revenue, sales volume, and gross profit, along with improved net profit.During the Year, OrbusNeich’s investments to strengthen its global sales and marketing capabilities, as well as expand product offerings, continued to yield positive results. The Group achieved revenue growth for the fifth consecutive year, reaching a record high of US$180.5 million. Additionally, sales volume in FY2025 hit a new high of 2.02 million units, representing a year-on-year growth of 16.2%, which included an increase of 13.1% from proprietary products and 34.9% from third-party products. Gross profit, up by 7.0% year-on-year, reached a record high of approximately US$122.4 million, with profit attributable to owners of the Company increasing by 5.5% to $41.9 million, and basic earnings per share rising by 5.8% to US5.09 cents.As at December 31, 2025, the Group maintained a strong financial position with cash and bank balances amounting to US$228.7 million. Taking into consideration OrbusNeich’s solid operating performance, healthy cash reserves and future capital requirements, the Board has proposed a final cash dividend of HK12 cents per share (2024: HK10 cents per share), up by 20% year-on-year. Alongside the special cash dividend of HK15 cents per share paid during the Year to celebrate OrbusNeich’s 25th anniversary and express gratitude for shareholders’ long-standing support, the total cash dividend for FY2025 will be HK27 cents per share.Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, “Building on 25 years of expertise, OrbusNeich achieved another strong performance in FY2025. Our commitment to product innovation and quality, and the establishment of dedicated local teams in diverse markets ensures that our products benefit vascular disease patients worldwide. During the Year, the Group advanced its strategy of building a comprehensive sales network while forging strategic collaborations, including providing commercialization support for Chinese medical device companies expanding overseas. Meanwhile, construction of our R&D and manufacturing base in Hangzhou is progressing steadily, reflecting our long-term growth ambitions.”Extensive Global Sales Network Fuels Strong Multi-Regional Revenue and Business GrowthOrbusNeich maintains an extensive sales network covering over 70 countries and regions through its 12 direct sales teams and distributor network, which includes the acquisition of a Taiwan-based distributor during the Year. During FY2025, the APAC region experienced a significant year-on-year increase in revenue of 15.7%, climbing to US$60.5 million, driven by strong performance in existing direct sales markets and the addition of the Taiwan market. Revenue growth in the EMEA region accelerated, rising by 19.6% to US$46.9 million, supported by rapid growth of over 20% in direct sales markets such as Germany, France, and Spain, along with substantial growth in distributor markets. As the impact of tariffs eased and product demand remained strong, revenue from the US market grew by 37.0% year-on-year, reaching US$21.2 million. Meanwhile, revenue from the Japan and PRC markets totaled US$32.3 million and US$17.8 million, respectively.In the second half of the year, the Group focused on strengthening its market presence in Europe and established a direct sales team in the Netherlands. The Group is establishing another direct sales team in Belgium in 2026, with the goal of achieving direct sales to local hospitals in both markets within the same year.OrbusNeich’s robust global sales network has attracted various manufacturers to collaborate with the Group on international market expansion. During the Year, the Group strengthened its partnership with SonoScape Medical Corp. by distributing their IVUS products across key APAC and European markets, including direct sales regions like Singapore, Malaysia, France, Germany, Spain, and Switzerland, as well as selected distributor markets in Europe. The IVUS products began generating sales in Hong Kong, Malaysia, Germany, and Spain by the end of FY2025.Strengthening a Diversified Portfolio via Parallel Global Registrations and Clinical TrialsAs at December 31, 2025, OrbusNeich owned more than 220 granted patents and published patent applications in key jurisdictions worldwide, as well as 35 PMDA-approved products, 42 CE-marked products, 20 FDA-cleared or approved products, and 24 NMPA-approved products.During the Year, the Group achieved progress in product registrations and clinical trials, including:Obtained PMDA approvals for Teleport Glide, Scoreflex QUAD, EZGuide LL (Large Lumen), Vascuaid and SIDEPASS, CE Marks for JADE PLUS and Teleport Glide, and NMPA approvals for the GuidingArk guiding catheter and Teleport XT;Submitted applications for FDA approval of Teleport Glide, PMDA approvals of Sapphire ULTRA and Sapphire NC ULTRA, and NMPA approvals of Scoreflex TRIO, Teleport Glide, Sapphire NC 24, Sapphire NC ULTRA, Sapphire ULTRA and JADE PLUS;Completed patient enrollment for the US clinical trial of Sapphire 3, with product registration expected to be submitted to the FDA in the first half of 2026;Completed patient enrolment of clinical registries for eucatech AG’s product eucaLimus and SUPPORT C, while patient enrollment for VITUS is still ongoing, with the goal of renewing CE Marks for these products under MDR by the end of 2027;Developing the proprietary coronary paclitaxel drug-coated balloon, Sapphire PTX, with a clinical trial application expected to be submitted to the PMDA in Q1 2026;Developing the peripheral scoring balloon, JADE Score, with registration applications expected to be submitted to the PMDA and the FDA in 2026.Optimizing Global Production Layout for Sustained Long-Term GrowthThe Group’s facilities in Shenzhen, the PRC; Hoevelaken, the Netherlands; and Weil am Rhein, Germany, achieved a combined annual production capacity of approximately 2.1 million units of balloons and stents as at December 31, 2025. To meet future production needs, construction of OrbusNeich’s largest R&D and manufacturing facility in Hangzhou, the PRC, is underway. Following the topping-out ceremony in the second half of 2025, marking the completion of construction of the main structure, renovation work has been ongoing since the end of 2025. The new facility is expected to commence operation in 2027, adding an annual production capacity of 2.4 million units.Mr. Chien concluded, “Looking ahead to 2026, OrbusNeich will continue leveraging its global platform to navigate ongoing external challenges. With the launch of new proprietary and eucatech AG products, rising third-party product sales, and the shift from distribution model to direct sales in certain markets, we expect steady revenue growth in the future. The Group will also explore potential downstream acquisitions in Europe to further consolidate our brand position. Going forward, we aim to sharpen our commercialization edge, maintain leadership in innovation and quality, and explore new business models to drive growth. Ultimately, these initiatives will reinforce our global competitiveness and further our founder, Mr. Teddy Chien’s vision of ‘benefitting humanity’ by improving patients’ quality of life worldwide.”About OrbusNeich Medical Group Holdings LimitedOrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.For more information, please visit the Group’s official website: https://orbusneich.com/.Media InquiriesStrategic Financial Relations LimitedAngelus LauTel: (852) 2864 4805Email: angelus.lau@sprg.com.hkDoris HoTel: (852) 2114 4916Email: doris.ho@sprg.com.hkBailey ZhouTel: (852) 2114 2825Email: bailey.zhou@sprg.com.hkWebsite: https://www.sprg.com.hk/OrbusNeich Medical Group Holdings Limited                                                   Maggie LauTel: (852) 3109 7234Email: mlau@orbusneich.comLucille Tsang Tel: (852) 3109 7292Email: ltsang@orbusneich.comWebsite: https://orbusneich.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

业聚医疗2025财年收入、销量及毛利齐创新高 纯利增至约4,200万美元 末期股息升两成至每股12港仙

业绩亮点:收入同比增长10.0%至1.80亿美元,连续五年创新高。销量破纪录,达202万件,同比增长16.2%。毛利上升7.0%至1.22亿美元新高;公司拥有人应占利润增长5.5%至约4,190万美元。董事会建议派发末期股息每股12港仙,连同特别股息,本年度现金股息总额达每股27港仙,派息比率为68.4%。财务状况稳健,年末现金及银行结余为约2.29亿美元,支持潜在收购及新生产设施建设。主要市场收入继续增长,亚太地区市场增长15.7%,欧洲、中东及非洲市场增长19.6%,及美国市场增长37.0%。集团积极透过其销售网络及专业知识,协助优质医疗器械同业的产品迈向全球,同时丰富自身的产品组合。其中一款合作产品已于香港、马来西亚、德国及西班牙上市,并正逐步推广至亚太及欧洲、中东及非洲地区更多市场。香港, 2026年3月12日 - (亚太商讯 via SeaPRwire.com) - 专营经皮冠状动脉介入治疗(PCI)及经皮腔内血管成形术(PTA)手术介入器械的全球医疗器械制造公司业聚医疗集团控股有限公司("业聚医疗"或"集团";股份代号:6929)今天宣布截至2025年12月31日止年度("2025财政年度"或"回顾年")的全年业绩。尽管外围环境充满挑战,集团仍展现非凡韧性,收入、销量及毛利齐创历史新高,纯利亦录得增长。回顾年内,业聚医疗在强化全球销售与营销能力及扩大产品组合投资方面,继续取得显著成效。集团收入连续五年实现增长,达180.5百万美元新高。2025财政年度销量亦创新高,同比增长16.2%至202万件,其中自有产品及第三方产品销量分别增长13.1%及34.9%。毛利同比增长7.0%至122.4百万美元,同创历史高位;公司拥有人应占利润增长5.5%至41.9百万美元。每股基本盈利上升5.8%至5.09美仙。于2025年12月31日,集团的财务状况维持稳健,现金及银行结余达约228.7百万美元。鉴于业聚医疗稳健的营运表现、充裕的现金储备及考虑到未来资本需求,董事会建议派发末期现金股息每股12港仙(2024年:每股10港仙)。连同较早前为庆祝业聚医疗成立25周年及答谢股东长期支持而派发的每股15港仙特别现金股息,2025财政年度的现金股息总额为每股27港仙。业聚医疗董事长、执行董事兼首席执行官钱永勋先生表示:"业聚医疗凭借过去25载建立的实力,于2025财政年度再创佳绩。我们一直坚持产品创新与品质至上的承诺,并建立专业团队扎根全球各主要市场,确保产品可惠及世界各地的血管疾病患者。本年度,集团持续扩展全球销售网络,同时推进多项策略性合作,包括为期望进军海外市场的中国医疗器械企业提供商业化支持。同时,我们位于杭州的研发及生产基地建设进展顺利,充分展现集团寻求长远增长的决心。"销售网络遍及全球,推动多区域收入及业务强劲增长业聚医疗的庞大销售网络,是由12个直销团队(包括本年度收购的一家台湾分销商)及分销商网络组成,遍及全球70多个国家和地区。2025财政年度,有赖现有直销市场的强劲表现及台湾市场的额外贡献,亚太地区收入同比大幅增长15.7%至60.5百万美元;欧洲、中东及非洲地区方面,德国、法国及西班牙等直销市场录得逾20.0%的快速增长,分销商市场亦增长显著,带动该区整体收入加速增长,上升19.6%至46.9百万美元。而随关税影响缓解加上产品需求持续强劲,美国市场收入同比增长37.0%至21.2百万美元。而日本及中国内地市场的收入分别为32.3及17.8百万美元。下半年,集团重点强化欧洲市场布局,在荷兰建立了直销团队。2026年,集团正于比利时设立另一直销团队,以期在同年于两地市场实现向医院直销。业聚医疗广泛的全球销售网络吸引了众多制造商携手合作,共同拓展国际市场。本年度,集团深化与深圳开立生物医疗科技股份有限公司的合作,于多个亚太及欧洲主要市场分销其血管内超声(IVUS)产品,涵盖新加坡、马来西亚、法国、德国、西班牙、瑞士等直销市场,以及欧洲数个选定的分销市场。于2025财政年底前,该产品已于香港、马来西亚、德国及西班牙市场实现销售。全球注册与临床齐头并进,强化多元创新产品组合截至2025年12月31日,业聚医疗在全球主要司法管辖区拥有超过220项授权专利及已公布专利申请,包括35款获PMDA批准产品、42款获CE标志产品、20款获FDA许可产品及24款获国家药监局批准产品。本年度,集团在产品注册及临床试验方面继续取得进展,包括:Teleport Glide、Scoreflex QUAD、EZGuide LL(大管腔)、Vascuaid及SIDEPASS获PMDA批准,JADE PLUS及Teleport Glide获CE标志,GuidingArk导引导管及Teleport XT获国家药监局批准;就Teleport Glide向FDA提交检准申请、就Sapphire ULTRA及Sapphire NC ULTRA向PMDA提交批准申请;就Scoreflex TRIO、Teleport Glide、Sapphire NC 24、Sapphire NC ULTRA、Sapphire ULTRA及JADE PLUS向国家药监局提交批准申请;完成Sapphire 3美国临床试验的病人入组工作,预计于2026年上半年向FDA提交产品注册申请;完成eucatech AG旗下产品eucaLimus及SUPPORT C的临床登记的病人入组,并进行VITUS的病人入组工作,目标于2027年底前取得MDR下的CE标志认证;开发自有冠状动脉紫杉醇药物涂层球囊Sapphire PTX,预计于2026年第一季向PMDA提交临床试验申请;开发外周刻痕球囊JADE Score,预计于2026年向PMDA及FDA提交注册申请。优化全球产能布局,实现可持续的长远增长集团位于中国深圳、荷兰荷佛拉肯及德国莱茵河畔魏尔的生产设施,于2025年12月31日的球囊及支架年产能达约210万件。为满足未来生产需要,集团正于中国杭州兴建旗下最大型的研发及生产设施。项目封顶仪式已于2025年下半年举行,标志该设施主体结构工程竣工,装修工程亦于2025年底启动。新设施预计于2027年投入营运,届时将新增年产能240万件。钱先生总结:"展望2026年,业聚医疗将继续善用全球平台应对当前外围挑战。随着自有新产品及eucatech AG产品推出、第三方产品销量持续增长,以及部分市场由分销转向直销模式,我们预期未来收入将稳步上升。集团亦将于欧洲物色潜在的下游收购目标,以进一步巩固品牌地位。未来,我们将继续强化商业化方面的竞争优势,保持产品创新与卓越品质方面的领先地位,并积极探索新业务发展模式,以达致增长。这些举措不仅能巩固集团的全球竞争力,更将延续创始人钱学雄先生‘造福人群’的初心与使命,为全球患者带来更美好的生活。"关于业聚医疗集团控股有限公司业聚医疗是一家全球医疗器械制造公司,专门生产用于经皮冠状动脉介入治疗(PCI)及经皮腔内血管成形术(PTA)的介入器械。本集团总部位于中国香港,产品销往全球超过70个国家和地区。集团亦积极将业务扩展至结构性心脏病领域。凭借拥有逾20年产品开发经验的内部研发团队,本集团已开发出世界领先的专有技术。如需了解详情,请访问集团官网:https://orbusneich.com/传媒垂询纵横财经公关顾问有限公司刘若琪电话:(852) 2864 4805电邮:angelus.lau@sprg.com.hk 何田田电话:(852) 2114 4916电邮:doris.ho@sprg.com.hk周百霖电话:(852) 2114 2825电邮:bailey.zhou@sprg.com.hk 网站: www.sprg.com.hk业聚医疗集团控股有限公司刘慧菁电话:(852) 3109 7234电邮:mlau@orbusneich.com曾 璐电话:(852) 3109 7292电邮:ltsang@orbusneich.com网站: https://orbusneich.com/ Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Unlocking the huge potential of China’s silver economy

HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – As the average age of the global population continues to rise, the Chinese Mainland is now home to the world’s largest number of seniors. Recognising this, the country’s 15th Five-Year Plan calls for proactive measures to address the challenges of an increasingly ageing population. The silver economy is set to be one of the vital engines for the mainland's next wave of economic growth.The Hong Kong Trade Development Council (HKTDC) has released a new consumer survey report, Chinese Mainland Silver Economy Opportunities, that details the strong spending power of the mainland’s affluent, middle-class senior consumers, as well as the vast untapped potential of this particular sector of society. With securing "happiness" and ensuring "quality" as their spending priorities, the survey shows that such consumers regard Hong Kong-made products as guaranteed to be authentic, while the city’s services sector is seen as professional and reliable. As a result, many of these consumers pronounce a willingness to pay a "Hong Kong premium".Believing that the continued expansion of the mainland's silver economy represents significant opportunities for Hong Kong businesses, Bruce Pang, HKTDC Director of Research, said: "Among other priorities, the 15th Five-Year Plan focuses on boosting domestic demand as a means of driving economic growth. Inevitably, this will create opportunities for Hong Kong companies looking to expand into the Chinese Mainland market.“By gaining a deeper understanding of the consumption patterns of mainland seniors, particularly those in the higher-spending middle-class and affluent segments, Hong Kong businesses will be able to effectively penetrate the domestic market."To gain a more in-depth understanding of the development opportunities in the country’s silver economy, HKTDC surveyed more than 2,000 middle-class/affluent senior consumers in various mainland cities last year. The broad cross-section of respondents included those in their 50s starting to plan their retirement, those entering retirement in their 60s, and the older post-retirement population (aged 70 and above). According to the survey’s findings, respondents' average monthly expenditure on daily consumer goods and services was approximately RMB7,000, rising to RMB8,000 for those in first-tier cities.Commenting on the findings of the survey, Wing Chu, the HKTDC’s Deputy Director of Research, who led the study, said: "Currently, the Chinese Mainland's silver economy is valued at about RMB7 trillion – some 6% of overall GDP. This is projected to surge to RMB30 trillion by 2035, indicating the segment’s huge development potential.“The survey also showed that more than half of such consumers had purchased Hong Kong products or services, consequently holding Hong Kong brands in particularly high regard. It was also notable that 78% of respondents were willing to pay a premium for Hong Kong-sourced products, while 84% were willing to do so in the case of the city’s services sector. Typically, respondents were willing to pay a 16.4% premium on products and 15.4% premium on services, with those in first-tier cities happy to pay an even higher percentage for many types of products and services.”Hong Kong brands enjoy stellar reputationOverall, many of the mainland’s senior consumers have a highly positive view of Hong Kong brands, with the city’s products celebrated for their quality and authenticity, and its services for their professionalism and reliability. On the product front, 61% of respondents had purchased Hong Kong products in the past year, including health foods (24%), luxury goods (18%) and beauty and personal care products (17%). In terms of future purchases, respondents expressed the greatest interest in Hong Kong health foods, leisure foods and beverages.Regarding the city’s services, 54% of senior respondents said they had utilised Hong Kong services in the past year, including beauty and personal care services (25%), travel to Hong Kong, Macao and Taiwan (22%) and financial and wealth management services (20%). Over the next 12 months, the most sought-after Hong Kong services were said to relate to health and wellness services, followed by beauty and personal care services.Digging deeper into the preferences of such consumers, HKTDC Economist Eric Chu said: "When choosing products and services, happiness is the priority for Chinese Mainland seniors, closely followed by value for money. With this in mind, Hong Kong businesses can leverage the silver economy by capitalising on the strong reputation and professional advantages of the city’s brands.“Specifically, they should consider expanding into the higher-spending first and second-tier cities, while targeting the younger segment of the senior population. Enhancing the offline experience and fostering word-of-mouth recommendations, alongside optimised promotional efforts, will also help Hong Kong businesses stand out in the mainland’s rapidly growing silver market.”Silver generation shaping a “blue ocean” of consumptionTaking a more in-depth look at the survey findings, 65% of respondents prioritised products or services that would enhance their leisure or bring them happiness, while 63% valued reasonable pricing and good value for money, and 62% focused more on the practicality and durability of the products or services on offer. Collectively, this indicates that mainland seniors are particularly concerned about their health and quality of life, while also valuing cost-effectiveness and functionality, marking them out as a notably mature and rational consumer group.In terms of product consumption, 23.3% of respondents most frequently purchased food and beverages, followed by home products (12.6%) and clothing (12.5%). In the case of services, 20.3% utilised body wellness services most often, followed by beauty and personal care services (16.7%) and leisure and entertainment services (13.1%).In addition, despite the popularity of online shopping across the mainland, the survey showed that physical stores remain the primary consumption channel for the more elderly demographic. For such consumers, offline experiences, in-person consultations and a sense of trust in products and services remain prime considerations.To help businesses capitalise on opportunities arising from the silver economy market, the HKTDC has incorporated various related elements into many of its exhibitions and forums. This allows relevant companies to showcase their products and technologies, while also giving them the opportunity to explore the latest industry developments through a series of related seminar programmes.Aligning with this approach, a thematic seminar on healthy ageing was held as part of the Asia Summit on Global Health, while the Rehabilitation and Elderly Care zone at the Hong Kong International Medical and Healthcare Fair featured the latest gerontechnology products. The Hong Kong Electronics Fair (Autumn Edition) also sought to showcase fitness and health products relevant to the senior market.In addition, the Hong Kong Toys & Games Fair, held in January this year, introduced a new “Happy Ageing” label for silver market products, making it easier for buyers to identify toys and related products designed specifically for older consumers. The Asia Toys & Games Forum, held during the fair, hosted a discussion by a number of international experts on the optimum design of toys for the elderly, while also offering many other insights into the silver-focused toy market.Looking ahead, the HKTDC will continue to provide comprehensive support to the business sector, enabling enterprises to further explore and develop opportunities in the growing silver economy market.ReferencesReport link: https://research.hktdc.com/en/article/MjI2ODIyMDg0NwHKTDC Research: http://research.hktdc.com/enPhoto download: https://bit.ly/4shpQjOHKTDC Director of Research Bruce Pang (centre), Deputy Director of Research Wing Chu (left) and Economist Eric Chu (right) presented key findings from the "Chinese Mainland Silver Economy Opportunities" consumer survey reportHKTDC Media Room: http://mediaroom.hktdc.com/enMedia enquiriesFor enquiries, please contact:Raconteur PR Agency:Betsy TseTel: (852) 9742 7338Email: betsytse@raconteur.hkMolisa LauTel: (852) 6187 7786Email: molisalau@raconteur.hkHKTDC Communication and Public Affairs Department:Clayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

More than 1,000 top buyers to attend! Procurement opportunities at China Chaoshan International Textile and Garment Exhibition

Shantou China, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) - From March 18 to 20, 2026, the 5th China Chaoshan International Textile and Garment Exhibition will be held at the Shantou International Convention & Exhibition Center, under the theme “Five Continents Gather in Chaoshan”.This year, the Exhibition has been fully upgraded in scale, covering over 150,000 square meters and featuring more than 100 product categories. It will bring together over 1,200 exhibitors showcasing more than 200,000 new products and bestsellers, and is expected to attract over 140,000 professional buyers seeking business opportunities.The buyers come from hundreds of cities and provinces across China, as well as more than 40 countries and regions overseas, encompassing Chinese and international purchasers, both online and offline buyers. The audience spans all channels, including e-commerce shelves, livestream e-commerce, cross-border platforms, ready-to-wear brands, private domain/group purchases, overseas trade, agents/distributors, brick-and-mortar chains, supermarkets/department stores, and well-known IPsThe appeal of the Exhibition lies in the quality and quantity of professional attendees. The 5th China Chaoshan International Textile and Garment Exhibition precisely matches the product categories of exhibitors with the needs of buyers, efficiently connecting partners and attracting the top procurement representatives across key channels within the industry, offering exhibitors unprecedented business opportunities.It brings together leading internet fashion brands and buyers, such as Bananain, Beneunder, NEIWAI, and Luckymeey, who drive online market growth and provide exhibitors with a golden channel for scalable exposure and precise user reach.Top KOLs, leading MCN (Multi-Channel Network) agencies, and livestreamers will unlock traffic potential, becoming a new engine for brands to amplify both awareness and sales.Leading lingerie retail chains integrate resources to efficiently meet the end-market procurement needs, building a stable, high-end channel network and providing brands with solid market penetration capabilities.Core regional agents and channel leaders in provincial and city-level markets cultivate local distribution networks and end-market operations, helping products achieve deeper market penetration and channel expansion.The Exhibition also gathers national-level chain supermarkets, high-end department store groups, and large shopping centers, providing large-scale physical venues that lay a solid foundation for offline retail partnerships.Mainstream cross-border platforms such as Amazon, eBay, SHEIN, and TEMU, along with major international and local e-commerce sellers, will participate, opening full-chain overseas opportunities for brands and helping enterprises enter the global textile and apparel consumer market.Representatives from leading e-commerce platforms, including Alibaba, POIZON, JD.com, Douyin, and VIP.com, will attend to connect with exhibitors, sharing insights on platform traffic and algorithm trends to drive online bestsellers and omni-channel growth.Top buyers from well-known lingerie brands will serve as partners guiding professional trends. Representatives from leading lingerie brands such as Aimer, Gujin, HODO, and FENTENG will be present, providing buyers with a fast-track to the full range of lingerie products.Top buyers from apparel brands bring mature brand matrices and customer bases, providing strategic channels to expand product reach and serve as partners in market breakthroughs and value enhancement.Invitations for professional buyers to the 5th China Chaoshan International Textile and Garment Exhibition are still ongoing, helping you explore more opportunities in the industry, secure real orders, and establish meaningful partnerships. We warmly invite industry friends to join us on-site and participate in this grand event!March 18 to March 20, 2026Shantou International Convention & Exhibition CenterWe sincerely invite you to attend and explore new opportunities in the industry.Media contactCompany Name: Shantou Zhongbo Exhibition Co., Ltd.Contact Person Name: James XiaoContact Person Title: General Manager AssistantOfficial Website: www.ctge.net/en/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Axonex Intelligence and Synergy Technology Group Form Joint Venture to Accelerate Digital Twin and Drone Flight Control Expansion

HONG KONG, Mar 12, 2026 - (ACN Newswire via SeaPRwire.com) – Mint Incorporation Limited (“Mint” or the “Group”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, today announced that its wholly-owned subsidiary, Axonex Intelligence Limited (“AXONEX”)  has entered into a joint venture agreement (the “JV Agreement”) with Synergy Technology Group Limited (“STG”) to establish Axonex Automation Limited (“JV company”), a new Hong Kong-based joint venture company focused on commercializing advanced digital twin and drone flight control technologies in Hong Kong and selected overseas markets.Under the JV Agreement, AXONEX will hold an 80% equity interest in Axonex Automation Limited, while STG will hold the remaining 20%. The joint venture will combine AXONEX’s operational resources and international business capabilities with STG’s proven technology in digital twins and drone flight control systems to drive scalable deployment in sectors such as infrastructure inspection, utilities, smart cities, and industrial operations.AXONEX has committed to provide up to HK$ 20,000,000 of capital to the joint venture in stages, subject to the achievement of defined business and technical milestones set out in the agreement. The funding will be released through four tranches over an expected 12–24-month period.STG will contribute technology, intellectual property, know-how, and ongoing technical support to the JV company, initially via a license of its core digital twin and drone flight control platforms, the “Zhishan No-Code Digital Twin Universal Platform and related drone inspection technologies” to Axonex Automation Limited.Mr. Damian Chan, Chairman of the Board and Chief Executive Officer of Mint stated: “This joint venture creates a focused vehicle to bring next-generation digital twin and autonomous drone capabilities from concept to commercial reality across Hong Kong and key overseas markets.”A representative of Synergy Technology Group Limited added: “Our collaboration with AXONEX will accelerate the real-world adoption of our digital twin and drone flight control technologies in critical infrastructure, smart city, and industrial applications, leveraging Hong Kong as a launchpad for global expansion.”Photo CaptionMr. Damian Chan, Chairman of the Board and Chief Executive Officer of Mint (Right) and Mr. Jiang Xiaotong, founder of STG (Left) signed the JV to establish Axonex Automation Limited focused on commercializing advanced digital twin and drone flight control technologies in Hong Kong and selected overseas markets.About Mint Incorporation LimitedMint Incorporation Limited (NASDAQ: MIMI), a Hong-Kong based enterprise listed on NASDAQ, specializes in artificial intelligence (AI), robotics, and interior design. Through its subsidiary Axonex Intelligence Limited, the company delivers intelligent robotics and facility management solutions to enterprises, real estate, shopping centers, government agencies, and more. Mint also operates Matter International Limited, providing professional interior design and renovation services. With a focus on innovation and practical applications, Mint is committed to enhancing efficiency, safety, and quality of life across industries.About Synergy Technology Group LimitedSynergy Technology Group Limited is a Hong Kong-based technology company specializing in advanced digital twin solutions and drone flight control systems, with applications across infrastructure monitoring, utilities, and smart city ecosystems. Founded by Jiang Xiaotong, an Associate Professor at Southeast University, Synergy Technology Group Limited operates under a license from Nanjing Zhishan Intelligent Technology Research Institute Co., Ltd for the “Zhishan No-Code Digital Twin Universal Platform and related drone inspection technologies”.Forward-Looking StatementsCertain statements in this release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results disclosed in the Company’s filings with the SEC. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Axonex Intelligence与互惠智科有限公司共同成立合资企业

香港, 2026年3月12日 - (亚太商讯 via SeaPRwire.com) - Mint Incorporation Limited("Mint"或"集团",纳斯达克股票代码:MIMI)─ 一家专注于人工智能与机械人技术,同时提供商业室内设计及装修服务的香港本地企业,今日欣然宣布,其全资子公司 Axonex Intelligence Limited ("AXONEX")已与互惠智科有限公司("互惠智科")订立合资协议,共同成立Axonex Automation Limited("合资企业"),一家总部位于香港,专注香港及特定海外市场将先进的数字孪生及无人机飞行控制技术商业化的新合资企业。根据合资协议,AXONEX将持有Axonex Automation Limited 80%的股权,而互惠智科将持有其余20%。这合资协议将结合AXONEX的营运资源与国际业务能力,及互惠智科在数字孪生与无人机飞行控制系统领域的成熟技术,以推动在基础设施检测、公用事业、智慧城市及工业营运等领域的可规模化部署。AXONEX 已承诺按阶段向合资企业投入最高达20,000,000港元的资金,具体金额将按协议所订明的业务及技术里程碑的达成情况而拟定。相关资金预计将于12至24个月期间内分四期拨付。互惠智科将向合资企业提供技术、知识产权、专业技能及持续的技术支援,初期将向Axonex Automation Limited授权其"止善零代码数字孪生通用平台"及无人机巡检相关业务。Mint董事会主席兼行政总裁陈海龙先生表示:"是次与互惠智科的合资协议将创建一个平台,专注将新一代数字孪生及自动驾驶无人机技术,在香港及多个重要海外市场从概念阶段推向商业应用。"互惠智科有限公司的代表补充道:"与AXONEX的合作将加速我们的数字孪生及无人机飞行控制技术在关键基础设施、智慧城市及工业应用领域的实际落地,并以香港为起点,实现全球业务拓展。"图片说明Mint董事会主席兼行政总裁陈海龙先生(右)与互惠智科创办人姜晓彤先生(左)签署合资协议,共同成立Axonex Automation Limited,专注香港及特定海外市场将先进的数字孪生及无人机飞行控制技术商业化。有关Mint Incorporation LimitedMint Incorporation Limited(纳斯达克股票代码:MIMI)是一家于纳斯达克上市的香港本地企业,专注于人工智能、机械人技术及室内设计领域。透过其子公司 Axonex Intelligence Limited,公司为企业、地产、商场、政府机构等提供智能机械人与设施管理解决方案。Mint 同时营运 Matter International Limited,提供专业室内设计与装修服务。秉持创新与实际应用并重的理念,Mint 致力于提升各行各业的效率、安全性与生活质素。有关互惠智科有限公司互惠智科有限公司是一家总部位于香港的科技企业,专门提供先进的数字孪生解决方案及无人机飞行控制系统,其应用领域涵盖基础设施监测、公共设施及智慧城市生态系统。由东南大学副教授姜晓彤创立,互惠智科有限公司获南京止善智能科技研究院有限公司所授予的许可,营运"止善零代码数字孪生通用平台"及"无人机巡检"相关业务。前瞻性陈述本新闻稿中的某些陈述属于前瞻性陈述。这些前瞻性陈述涉及已知和未知的风险和不确定性,并基于公司对可能影响其财务状况、营运成果、业务策略和财务需求的未来事件的目前期望和预测。投资者可通过"大约"、 "相信 "、 "希望 "、 "期望 "、 "预期 "、 "估计 "、"项目 "、 "打算 "、 "计划 "、 "将 "、 "将会 "、 "应该"、 "可能"或其他类似的词语或短语识别这些前瞻性陈述。公司不承担更新或修订任何前瞻性陈述以反映随后发生的事件或情况,或其期望的变化的公开义务,除非法律要求。尽管公司认为这些前瞻性陈述所表达的期望是合理的,但无法保证这些期望将会被证实正确,并提醒投资者实际结果可能与预期结果有显著差异,并鼓励投资者查阅可能影响其未来结果的其他因素,这些因素披露在公司向证券交易委员会提交的文件中。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its annual results for the year ended 31 December 2025.Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG Guoxiong (center), Executive Director and Chief Executive Officer Ms. OU Haijing (left), and Chief Financial Officer Mr. KWAN Chi Fai (right)2025 Annual Results Highlights:                                                    - Overall operation remained resilient, with total revenue of RMB1,856 million (2024: RMB2,032 million).- The average financing cost was 3.61%, a three-year low; the average interest payment rate was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding exchange loss, the financing expenses decreased by approximately RMB152 million year-on-year.- As at 31 December 2025, the overall occupancy rate of the properties was 82.1% (2024: 84.5%).- Optimised the asset portfolio by disposing of a 50% interest in Yuexiu Financial Tower in Q4 2025, realising cash proceeds of approximately RMB5.3 billion to enhance financial flexibility. Yuexiu REIT maintained its "investment-grade" rating from both Standard & Poor's and Fitch, with the outlook upgraded to "stable".- The final distribution to the Unitholders for the period will be approximately RMB0.0189, equivalent to HK$0.0214. Distribution per Unit for the year will be approximately RMB0.0522, equivalent to HK$0.0580. Distribution yield is 6.74% per Unit for the year.- To maintain the REIT’s financial flexibility, the distribution ratio for the period from 1 July 2025 to 31 December 2025 has been adjusted to 90%, resulting in an overall full-year distribution ratio of approximately 96%.Guangzhou International Finance Center (GZIFC):- Operating revenue of the GZIFC complex was RMB984 million, accounting for 53.0% of the REIT’s total revenue.- The office building of GZIFC introduced two Fortune Global 500 companies; the occupancy rate was 80.9%.- GZIFC Shopping Mall introduced China Duty Free Group (CDFG), the first and currently the only downtown duty-free store in Guangzhou, achieving a renewal rate of 89% for the year, and an occupancy rate of 95.5% at the end of the period.- Four Seasons Hotel Guangzhou's average room rate increased by 5.8% year-on-year. Ascott Serviced Apartments GZIFC achieved an average occupancy rate of 91.5%, up 1 percentage point year-on-year, with revenue reaching a record high for the period.Proactive Management of Financing Risk and Effective Stabilisation of Financing Cost- With regard to the short-term loan of RMB530 million, the 5-year syndicated loan of HK$2.1 billion, and the remaining HK$2.1 billion of the 3-year syndicated loan of HK$3.8 billion, all due in 2025, the Manager in 2025 renewed the short-term loan of RMB530 million, obtained offshore loan of RMB1.7 billion, issued dim sum bonds of RMB1 billion, and obtained an offshore syndicated loan package equivalent to HK$2.1 billion (a sustainability-linked loan), for the refinancing of the maturing loans so as to ensure effective monitor on the liquidity risk.- A total of approximately RMB4.68 billion in loans were obtained in 2025 to partially refinance offshore HKD floating rate loans, taking advantage of the relatively low-cost of RMB financing to proactively adjust the financing structure. At the end of 2025, the financing interest rate exposure of Yuexiu REIT was approximately 10%, narrowed by 16 percentage points from 26% at the beginning of the year; the average financing cost was 3.61%, a three-year low, representing a decrease of 55 basis points from 4.16% at the beginning of the year; the average interest payment rate for the full year of 2025 was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding the exchange loss, the finance expenses were approximately RMB773 million, representing a year-on-year decrease of approximately RMB152 million.- As at the end of 2025, Yuexiu REIT had RMB financing of approximately RMB15.47 billion, accounting for 76% of total financing (2024: RMB financing of approximately RMB12.33 billion, accounting for 60% of total financing).Mr. JIANG Guoxiong, Chairman and Non-Executive Director of Yuexiu REIT, said, "2025 marked the 20th anniversary of Yuexiu REIT's listing. The Manager consolidated its competitive advantages by taking strategic actions to secure market share, prioritised occupancy rates, strengthened risk control to stabilise lease renewals, enhanced product competitiveness to meet market demand and invested in capital renovation projects to ensure asset value preservation and appreciation. These efforts stabilised the fundamentals of operations in a challenging market, providing solid support for the full-year revenue. Concurrently, we optimised the asset portfolio by appropriately reducing the proportion of office buildings, and proactively captured favourable financing opportunities, successfully issuing the first-ever Panda Bonds by a listed REIT globally as well as the REIT’s inaugural green bond. Financing costs for the year reached a three-year low, effectively underpinning the overall distribution level. The successful execution of a series of pioneering capital operations fully demonstrated the Manager’s strategic commitment to driving the high-quality development of Yuexiu REIT. This underscored its resolute determination in creating sustainable and long-term value for Unitholders.”Guangzhou International Finance Center (GZIFC)During the year, GZIFC recorded a newly contracted area of 15,702 sq.m. The newly launched 7,403 sq.m. of furnished units recorded an absorption cycle of about 36 days, with an absorption rate close to 72%. Quality tenants introduced include two Fortune Global 500 companies, a Fortune China 500 company, a leading global shipping giant, and a renowned Internet-based culture, sports and entertainment company. In addition, the project recorded a renewal area of 34,294 sq.m. and a renewal rate of 86%, retaining quality tenants including six Fortune Global 500 companies and a foreign consulate. GZIFC was selected as one of the Top 30 companies in the “Performance Index - 2025 Commercial Property Operation Performance)” by Guandian.GZIFC Shopping Mall renewed lease with its anchor tenant, Guangzhou Friendship Store, and introduced China Duty Free Group (CDFG) to set up a store, which is the first and currently the only downtown duty-free store in Guangzhou. In addition, GZIFC Shopping Mall launched the light meal and beverage area on the basement floor, coupled with the brand revitalisation of the dining tenants on the fourth and fifth floors by introducing seven “first stores”. Membership operations achieved remarkable results, with the share of member sales doubling to 16%. The project actively created digitalised consumption scenarios and made full use of mainstream platforms to attract customer flow through multiple channels. Specifically, the “Italian Culture Season” themed event was successfully held in collaboration with hotels, theaters, museums and consulates, effectively boosting customer flow and sales. Newly contracted area and renewal area totaled 35,573 sq.m., with a renewal rate of 89%. The occupancy rate was 95.5%.Four Seasons Hotel Guangzhou launched the first batch of renovated rooms during the year. The average room rate was RMB2,260, representing a year-on-year increase of 5.8%. The average occupancy rate was 77.7%. The revenue per available room (RevPAR) was RMB1,756, representing a year-on-year increase of 0.9%. The RevPAR competitive index was 110.0, maintaining a relatively leading market position among luxury hotel competitors. Ascott Serviced Apartments GZIFC recorded an average occupancy rate of 91.5% during the year, representing a year-on-year increase of 1 percentage point. The average room rate was RMB1,137, representing a year-on-year increase of 1.6%. The RevPAR was RMB1,040, representing a year-on-year growth of 2.7%. The RevPAR competitive index reached 146.9, remaining at a high level among high-end apartment competitors. The Apartments achieved a record high in operating revenue for the same period and ranked first in operating revenue among Ascott China properties for ten consecutive years since 2016.Yuexiu Financial TowerThe Manager disposed of 50% interest in Yuexiu Financial Tower in Q4 2025. Following completion of the disposal, Yuexiu Financial Tower became a Qualified Minority-owned Property of the REIT. The occupancy rate was 77.9% at the end of the period.White Horse BuildingWhite Horse Building introduced high-quality customers from core industrial clusters in Guangzhou, Shenzhen and Dongguan and recorded a newly contracted area of 5,808 sq.m. for the year, with full occupancy on the 1st floor for the first time in the past five years and a six-year record high set by the 2nd floor’s occupancy rate. During the year, it organised 22 original brands to showcase their products at professional exhibitions such as the Fashion World Tokyo, and the China International Fashion Fair; held the “White Horse Fashion Journey: Border Trade Supply Chain Matching Conference”, and established the “Guangdong-Xinjiang Fashion Industry Chain Supply and Procurement Cooperation Alliance” with ten wholesale markets in Urumqi, Xinjiang. During the year, it welcomed a total of 517 procurement delegations, along with nearly 13,000 purchaser visits, including 19 foreign delegations from France, Vietnam and other countries, and facilitated procurement deals worth RMB320 million. The occupancy rate was 96.0% at the end of the period.Fortune PlazaDuring the year, the project recorded a newly contracted area of 6,334 sq.m., and introduced certain quality tenants including several subsidiaries of a Fortune Global 500 integrated financial group, two Fortune Global 500 companies and the Guangzhou branch of two global leading companies. The project recorded a renewal area of 8,662 sq.m. and a renewal rate of 84.0%, retained quality tenants including three Fortune Global 500 companies and the Guangzhou branch of a national commercial bank. Upgraded product standards accelerated the absorption of vacant units, with an absorption rate of 93% for furnished units. The occupancy rate was 93.4% at the end of the period, representing a year-on-year increase of 1 percentage point, and a strong rebound of 5.4 percentage points from the interim period.City Development PlazaDuring the Reporting Year, the project recorded a newly contracted area of 9,279 sq.m. and introduced a beauty technology company and a pharmaceutical supply chain service company to enhance the ambience of healthcare business in the building. The project recorded a renewal area of 5,011 sq.m. and a renewal rate of 77%, retained tenants including a Fortune Global 500 company and a globally-renowned Contract Research Organisation (CRO). The occupancy rate was 90.6% at the end of the period.Victory PlazaVictory Plazq’s anchor tenant, Uniqlo, continued to play a flagship role, recording a 7.0% year-on-year sales growth for the year and maintaining its position as the top-selling store nationwide. The project successfully introduced the sports brand “Super Anta” to set up the largest store in the Guangzhou-Foshan region and “Crab Mang Mang”, the first store nationwide of Guizhou spicy crab business, achieved the diversification of its food and beverage brand portfolio. By connecting internal and external resources to hold fifteen major events, the mall achieved a year-on-year increase of 2.0% in its annual sales. During the year, newly contracted area and renewal area totaled 5,579 sq.m., with a renewal rate of 84%. The occupancy rate was 94.0% at the end of the period.Shanghai Yue Xiu TowerDuring the year, Shanghai Yue Xiu Tower recorded a renewal area of 6,430 sq.m., with a renewal rate of 43%, while securing a newly contracted area of 8,070 sq.m., efficiently making up for the prematurely vacated units. During the year, the project continued to increase the supply of small-area furnished units to meet market demand, formulated differentiated pricing strategies, and successfully held a channel recruitment conference, which attracted more than one hundred real estate agencies. By investing in various capital nature renovations, the project enhanced both energy efficiency and service standards. The occupancy rate was 83.1% at the end of the period.Wuhan PropertiesDuring the year, Wuhan Yuexiu Fortune Centre recorded a newly contracted area of 26,837 sq.m., and introduced quality tenants including two Fortune Global 500 state-owned enterprises, and two Fortune Global 500 foreign enterprises. In addition, it recorded a renewal area of 20,617 sq.m. and a renewal rate of 76.0%, hitting a new high in the past three years, and retained quality tenants, including seven Fortune Global 500 enterprises and a Fortune China 500 company. Approximately 21,000 sq. m. of renovated units were supplied throughout the year, with an absorption rate approaching 98%. The occupancy rate was 62.1% at the end of the period, representing a year-on-year increase of 1 percentage point.Wuhan Starry Victoria Shopping Centre revitalised several popular dining and fitness brands, aiming to attract more family and young customer groups. The project deeply tapped into the consumption potentials of “night economy” and “scene experience” by leveraging the unique venue feature of “Joy Garden”, launching themed activities such as “Riverside Starry Night ”, thus achieving customer flow substantially in line with last year, while the shopping mall recorded a year-on-year increase of 0.5% in annual sales. During the year, newly contracted area and renewal area totaled 9,827 sq.m., with a renewal rate of 48.0%. The occupancy rate was 87.4% at the end of the period, representing a rebound of 5.0 percentage points from the interim period.Hangzhou VictoryDuring the year, the project recorded a newly contracted area of 7,890 sq.m. and introduced a tenant to take up an entire floor. In addition, it recorded a renewal area of 8,836 sq.m. and a renewal rate of 54%, retained quality tenants including two Fortune Global 500 companies and the Zhejiang branch of a state-owned enterprise in Shanxi Province. The occupancy rate was 84.5% at the end of the period.Integrating ESG into Business and Promoting Sustainable DevelopmentAdhering to a long-term perspective, the Manager systematically advanced ESG initiatives. On the occasion of publicly disclosing Yuexiu REIT’s sustainability practices for the tenth consecutive year, the Manager officially renamed the “Environmental, Social and Governance Report” to the “Sustainability Report”, further promoting the deep integration of Yuexiu REIT’s strategy into sustainable development and reinforcing their synchronized progress. During the year, Yuexiu REIT received the highest Green Five Star rating and the title of “Global Sector Leader” for the first time from the Global Real Estate Sustainability Benchmark (GRESB) and once again secured A-rating (highest level) for public disclosure, highlighting its outstanding capabilities in the field of sustainable development.ProspectsIn the coming year, the Manager will maintain a prudent and optimistic attitude, adapt proactively to changes and strengthen risk managemen to generate stable return for the Unitholders. In terms of asset management, the Manager will dynamically implement proactive, prudent and flexible leasing and operating strategies in response to economic development trends and competitive dynamics, diligently explore new growth drivers, and keenly seize potential opportunities to enhance the market competitiveness of asset portfolio. In terms of financing management, the Manager will continue to review and make reasonable adjustments to its financing structure, and introduce low-cost RMB financing through various financing channels to offset interest rate risks. In respect of renovation projects, the Manager will carry out the phased renovations of Four Seasons Hotel Guangzhou in an orderly manner to support the long-term preservation and appreciation of property value.About Yuexiu Real Estate Investment TrustYuexiu Real Estate Investment Trust ("Yuexiu REIT") was listed on the Hong Kong Stock Exchange of Hong Kong Limited on 21 December 2005 and is the first listed real estate investment trust only investing in properties in the People's Republic of China (the "PRC") in the world. As of 31 December 2025, Yuexiu REIT’s portfolio of properties consisted of ten properties (including one Qualified Minority-owned Property), namely, White Horse Building, Fortune Plaza, City Development Plaza, Victory Plaza, Guangzhou International Finance Centre (“GZIFC”), Yuexiu Financial Tower (a Qualified Minority-owned Property with a 49.495% beneficial interest) located in Guangzhou; Yue Xiu Tower located in Shanghai; Wuhan Yuexiu Fortune Centre, and Starry Victoria Shopping Centre located in Wuhan; Victory Business Centre located in Hangzhou; and Yue Xiu Building located in Hong Kong. The total gross floor area of the properties (excluding Yuexiu Financial Tower) was approximately 974,000 sq.m. All properties are located in the central business district of Guangzhou, Shanghai, Wuhan, Hangzhou and Hong Kong respectively. The categories of the properties include Grade-A offices, commercial complexes, retail business, hotel, serviced apartments and professional clothing market etc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

云顶新耀维适平(R)中国大陆首张处方落地 填补中重度溃疡性结肠炎治疗空白

香港, 2026年3月11日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀(01952.HK)宣布,旗下自身免疫性疾病领域核心产品维适平(R)(精氨酸艾曲莫德片,VELSIPITY(R))中国大陆首张处方在3月9日于中山大学附属第一医院开出,标志着这款创新疗法正式进入中国临床应用阶段。据悉,在中国大陆首方开具当天,维适平(R)已在广州、上海、杭州、西安、重庆、北京和南京7个核心城市的8家三甲医院同步开出处方,实现上市首日即覆盖全国重点区域患者,并通过互联网医院渠道进一步扩大患者覆盖范围。目前,该药物已在中山大学附属第一医院、浙江大学医学院附属邵逸夫医院、中国人民解放军空军军医大学第一附属医院、重庆市人民医院、中国医学科学院北京协和医院等多家核心医疗机构惠及患者。值得关注的是,维适平(R)于今年2月获得国家药监局批准上市,仅一个月便实现中国大陆首方落地,推进速度明显快于行业平均水平。业内认为,这不仅反映出该产品较高的临床需求,也体现了云顶新耀在创新药商业化方面的执行效率。从疾病负担来看,炎症性肠病(IBD)已被认为是全球增长最快的消化系统疾病之一。IBD主要包括溃疡性结肠炎(UC)和克罗恩病(CD)。近年来,随着饮食结构变化、生活方式改变以及诊断水平提升,中国患者数量持续增加。多家行业研究机构预计,到2030年前后,中国IBD治疗市场规模有望突破百亿元人民币,其中新型小分子创新药将成为主要增长动力之一。从临床需求来看,溃疡性结肠炎是一种病因尚不明确、易复发的慢性肠道炎症性疾病,临床表现为黏液血便、腹痛、腹泻、里急后重等症状,严重影响患者长期生活质量。近年来,中国该病发病率和患病率持续上升且呈年轻化趋势,预计患者人数将由2025年的约98万增长至2031年的约150万。目前该病仍无法治愈,患者需长期用药维持疾病控制,而传统疗法疗效有限、生物制剂存在“疗效天花板”,临床亟需能实现更稳定、持久疾病控制的创新方案。维适平(R)作为每日口服一次的新一代高选择性S1P受体调节剂,具备最佳药物(best-in-disease)潜质,已获得美国胃肠病学协会(AGA)临床实践指南与美国胃肠病学会(ACG)临床指南强烈推荐,作为中重度溃疡性结肠炎的一线用药。多项全球临床研究证实其疗效与安全性良好,尤其在快速起效、实现无激素缓解及深度黏膜愈合方面具有明显临床优势。在迄今最大规模的中重度UC患者亚洲多中心III期临床研究(ENLIGHT UC)中,维适平(R)维持治疗40周,临床缓解率达48.1%,深度黏膜愈合率达51.9%,内镜正常化率达45.5%。数据显示,维适平(R)可实现强效深度黏膜愈合,从而改善疾病长期预后,并有助于降低复发及癌变风险。全球Ⅲ期ELEVATE研究的一项开放标签扩展研究数据证实,持续维适平(R)治疗3年,在观察病例中,86.8%患者实现临床应答,临床缓解率和黏膜愈合率均维持在约60%水平。全球临床研究随访5年的数据进一步表明其稳定且良好的安全性特征,整体耐受性良好。中华医学会消化病学分会前任主任委员、中山大学附属第一医院消化内科学术带头人陈旻湖教授指出,维适平(R)此次首张处方的开具,有望进一步优化溃疡性结肠炎的临床管理路径,推动疾病治疗向更高水平发展,实现黏膜愈合的治疗目标,惠及更多患者。云顶新耀首席执行官罗永庆表示,黏膜愈合是当前溃疡性结肠炎的治疗目标,尽早实现可大幅降低患者疾病复发率、住院率、手术率和癌变风险。维适平(R)可从源头控制肠道炎症,促进黏膜愈合,填补了中重度溃疡性结肠炎治疗领域的空白。作为一款治疗溃疡性结肠炎的创新一线治疗药物,维适平(R)兼具“疗效、安全性及方便性”三重优势,为患者提供长期疾病控制与生活质量改善的保障。此外,该药物于2024年和2025年被纳入粤港澳大湾区内地9市临床急需进口港澳药品医疗器械目录,在大湾区率先实现临床应用,且在真实诊疗场景中的表现与临床研究疗效、安全性一致。商业化层面,云顶新耀已通过肾科核心产品耐赋康(R)验证了成熟可复制的商业化能力。作为全球首个且目前唯一在中、美、欧获得完全批准的IgA肾病对因治疗药物,耐赋康(R)在2025年前三季度销售额突破10亿元,创造了非肿瘤产品的历史,成为过去十年慢病药进医保销售最好的产品。该产品的成功,验证了以“科学及商业洞察驱动的准入、医学、市场、销售一体化协同(A2MS)”为核心的创新药商业化运营平台,也为后续产品的市场拓展提供了可复用的体系与经验。此次维适平(R)首方快速落地,进一步印证了该平台的高效性,依托耐赋康(R)的渠道网络与市场准入经验,其有望复刻增长路径。从市场格局来看,长期以来中国溃疡性结肠炎治疗市场以传统免疫抑制剂和注射型生物制剂为主,这些方案存在口服便利性不足、长期安全性风险等问题。维适平(R)凭借差异化优势,被业界认为有望填补这一需求缺口,行业普遍预期其销售峰值可达50亿元,成为驱动云顶新耀业绩增长的重要引擎。云顶新耀表示,将构建多渠道准入体系,提供多元化患者援助项目和创新支付方案,并全力推动维适平(R)纳入国家医保目录,以提升药物的可及性和可负担性。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

越秀房产基金经营保持韧性 2025年收入逾人民币18亿元

香港, 2026年3月11日 - (亚太商讯 via SeaPRwire.com) - 越秀房地产投资信托基金( 〝越秀房产基金〞,连同越秀房托资产管理有限公司,统称〝基金〞;股份代号:405)公布其截至2025年12月31日止之全年业绩。越秀房产基金管理团队:主席及非执行董事江国雄先生(中)、执行董事及行政总裁区海晶女士(左)、财务总监关志辉先生(右)2025年全年业绩摘要:- 整体经营保持韧性,收入总额为人民币18.56亿元(2024年:人民币20.32亿元)。- 平均融资成本为3.61%,创近三年新低;平均付息率3.77%,同比下降76个基点,剔除汇兑亏损的融资成本同比减少约1.52亿元人民币。- 于2025年12月31日,物业整体出租率为82.1%(2024年同期:84.5%)。- 优化资产组合,于第四季度出售越秀金融大厦50%权益,回笼约人民币53亿元现金提升财务灵活度,获标普和惠誉维持〝投资级〞评级,并上调评级展望至〝稳定〞。- 末期分派每个基金单位约人民币0.0189元,约等于0.0214港元。全年度之每个基金单位分派约人民币0.0522元,约等于0.0580港元。按年计算的分派收益率为6.74%。- 为保持基金财务灵活性,于2025年7月1日至2025年12月31日期间的分派比率调整为90%,全年整体分派比率约为96%。广州国金中心:- 广州国金中心综合体录得经营收入为人民币9.84亿元,占基金收入总额53.0%。- 广州国金中心写字楼引进两家财富世界500强企业;出租率为80.9%。- 国金天地引进广州首家且目前唯一的市内免税店〝中免免税店〞,全年续租率89%,期末出租率95.5%。- 广州四季酒店平均房价同比提升5.8%,国金中心雅诗阁服务式公寓平均入住率达91.5%,同比增长1个百分点,营业收入创历史同期新高。积极管理融资风险,有效平抑融资成本- 针对2025年到期的人民币5.3亿元短期贷款、21亿港元5年期银团贷款以及38亿港元3年期银团贷款余下21亿港元,管理人于2025年完成人民币5.3亿元短期贷款续借,并通过取得17亿元人民币离岸贷款、发行10亿人民币点心债以及21亿港元等值境外银团组合贷款(为可持续发展挂钩贷款),用于到期贷款的再融资,确保流动性风险得到有效管控。- 年内合计引入人民币46.8亿元贷款,并部分置换境外浮息港元贷款,利用人民币融资相对低位,主动调节融资结构。2025年年末融资利率敞口约为10%,较年初26%收窄16个百分点;平均融资成本为3.61%,创近三年新低,较年初4.16%下降55个基点;2025年全年平均付息率3.77%,同比下降76个基点。剔除汇兑亏损的融资成本约为人民币7.73亿元,同比减少约人民币1.52亿元。- 2025年年末人民币融资约154.7 亿元,占总体融资76%(2024年:人民币融资约123.3 亿元,占总体融资60%)。越秀房产基金主席及非执行董事江国雄先生表示:〝2025年是越秀房产基金上市二十周年。管理人巩固优势,策略性抢占市场份额,以出租率为优先考虑,强化风险管控稳定续租,匹配市场需求增强产品竞争力,投入资本性改造确保资产保值增值,在充满挑战的市场中稳定经营基本面,为全年经营收入提供坚实支撑。与此同时,我们优化资产组合,适当降低写字楼业态占比,并敏锐捕捉有利融资窗口,先后成功发行全球首笔上市REITs‘熊猫债’及基金首笔绿债。全年融资成本创近三年新低,有效支撑整体分派水平。一系列开创性资本运作的成功实施,充分彰显管理人推动越秀房产基金高质量发展的战略目标,展现管理人为基金单位持有人创造可持续长远价值的坚定决心。〞国金中心国金中心年内新签15,702平方米。推出7,403平方米带装修单元,去化周期约36天,去化率接近72%。引进优质租户包括两家财富世界500强背景企业、一家财富中国500强企业、一家全球龙头航运企业和一家知名互联网背景文体娱乐企业,续租34,294平方米,续租率86%,留存优质租户包括六家财富世界500强企业和一家外国领事馆。国金中心入选观点〝表现力指数·2025商办资产运营表现〞TOP30榜单。国金天地完成主力租户〝广州友谊商店〞续租;引进广州首家且目前唯一的市内免税店〝中免免税店〞;落地负一层轻餐茶饮区、四楼和五楼餐饮业态品牌焕新,引进七家〝首店〞。会员运营成效显著,会员销售占比翻倍式提升至16%。积极打造电子化消费场景,充分利用主流平台多渠道引流。联动酒店、大剧院、博物馆、领事馆成功举办〝意大利文化季〞主题活动,有效促进客流与销售转化。新签和续租合计35,573平方米,续租率89%。出租率为95.5%。广州四季酒店年内首批改造客房年内入市,平均房价为人民币2,260元,同比提升5.8%,平均入住率为77.7%;每间可供出租客房收入(RevPAR)为人民币1,756元,同比增长0.9%;RevPAR竞争指数为110.0,在奢华酒店竞争群组中始终保持较领先的市场地位。国金中心雅诗阁服务式公寓期内平均入住率为91.5%,同比上升1个百分点;平均房价为人民币1,137元,同比提升1.6%;RevPAR为人民币1,040元,同比增长2.7%;RevPAR竞争指数达146.9,在高端公寓竞品市场中维持高位。公寓营业收入创历史同期新高,经营收入自2016年起连续十年稳居雅诗阁集团中国区第一名。越秀金融大厦管理人于第四季度出售越秀金融大厦50%权益。出售完成后,越秀金融大厦成为基金合资格少数权益物业。期末出租率为77.9%。白马大厦白马大厦引入广州、深圳和东莞核心产业集群优质客户,带动全年新签5,808平方米,一楼实现近五年首次满租,二楼出租率创近六年新高。年内组织22家原创品牌亮相日本东京时尚产业展、及中国国际服装服饰博览会等专业展会;开展〝白马时尚行 · 边贸供应链对接会〞,与新疆乌鲁木齐十家批发市场建立〝粤新服饰产业链供采合作联盟〞。全年累计接待517个采购团,累计接待采购商近1.3万人次,其中包括来自法国、越南等19个外商团,促成采购金额达人民币3.2亿元。期末出租率为96.0%。财富广场财富广场全年新签6,334平方米,成功引进多家优质租户,包括一家财富世界500强综合金融集团旗下多家企业、两家财富世界500强背景企业和两家全球行业龙头企业的广州分支机构。续租8,662平方米,续租率84.0%,包括三家财富世界500强背景企业和一家全国性商业银行广州分行。升级产品标准加快空置单元去化,带装修单元去化率达93%。期末出租率为93.4%,同比上升1个百分点,出租率较中期强劲回升5.4个百分点。城建大厦城建大厦年内新签9,279平方米,引进一家美容科技企业和一家医药供应链服务企业,提升楼内大健康业态氛围。续租5,011平方米,续租率77%,包括一家财富世界500强企业和一家全球知名合同研究组织(CRO)企业。期末出租率为90.6%。维多利广场维多利广场主力租户〝优衣库〞继续发挥旗舰作用,全年销售额同比增长7.0%,蝉联全国门店榜首。成功引进运动品牌〝超级安踏〞,打造广佛地区最大门店;成功引入贵州香辣蟹全国首店〝蟹莽莽〞,丰富餐饮品牌组合。联动内外部资源举办十五场大型活动,实现商场全年销售额同比增长2.0%。全年新签和续租合计5,579平方米,续租率84%。期末出租率为94.0%。上海越秀大厦上海越秀大厦全年续租6,430平方米,续租率43%;新签8,070平方米,有效填补退租单元。持续匹配市场需求增加小面积带装修单元供应,制定差异化定价策略,成功举办渠道招商会,吸引百家中介机构参与,并投入多项资本性改造推动节能效益和服务水平持续提升。期末出租率为83.1%。武汉物业武汉越秀财富中心年内新签26,837平方米,引进优质租户包括两家财富世界500强背景央企和两家财富世界500强背景外资企业。续租20,617平方米,续租率76.0%创近三年新高,留存优质租户包括七家财富世界500强背景企业和一家财富中国500强背景企业。全年改造单元供应约2.1万平方米,去化率接近98%。期末出租率为62.1%,同比上升1个百分点。武汉星汇维港购物中心年内焕新多家热门餐饮和健身品牌,吸引更多家庭和年轻客群,依托〝悦花园〞场地特色深度挖掘〝夜经济〞与〝场景体验〞消费潜力,举办〝江畔星夜〞主题活动,实现客流量同比基本持平,商场年度销售额同比提升0.5%。全年新签和续租合计9,827平方米,续租率48.0%。期末出租率为87.4%,较中期回升5.0个百分点。杭州维多利杭州维多利全年新签7,890平方米,引进一家全层租户。续租8,836平方米,续租率54%,留存优质租户包括两家财富世界500强背景企业和一家山西省属国企的浙江分公司。期末出租率为84.5%。ESG融合业务,推进可持续发展管理人秉承长期主义理念,系统布局ESG工作,值此连续第十年对外披露越秀房产基金可持续发展实践之际,管理人正式将〝环境、社会及管治报告〞更名为〝可持续发展报告〞,以此进一步促进越秀房产基金战略与可持续发展深度融合、同频共进。年内,首次荣获全球房地产可持续发展基准(GRESB)最高绿色五星评级及〝全球行业领导者〞称号,公开披露再次获最高〝A〞级等,彰显了在可持续发展领域的卓越实力。未来展望未来一年,管理人将保持审慎乐观的态度,〝以变应变〞强化风险管理,致力为基金单位持有人创造稳定回报。资产管理方面,将因应经济发展走势和竞争环境演变,动态实施积极、稳健、灵活的租赁和营运策略,发掘新增长点、把握潜在机会提升资产组合市场竞争力。融资管理方面,将持续对融资结构进行合理调整,通过各类融资途径引入低成本人民币融资,平滑利率风险。工程改造方面,将有序分段改造广州四季酒店,护航物业长效保值增值。关于越秀房地产投资信托基金越秀房地产投资信托基金(〝越秀房产基金〞)于2005年12月21日在香港联交所上市,为全球首只投资于中国内地物业的上市房地产投资信托基金。截至2025年12月31日,越秀房产基金之物业组合共有十项(包括一项合资格少数权益物业),分别位于广州的白马大厦、财富广场、城建大厦、维多利广场、广州国际金融中心、越秀金融大厦(合资格少数权益物业,实益权益49.495%)、位于上海的越秀大厦、位于武汉的武汉越秀财富中心、星汇维港购物中心、位于杭州的维多利商务中心及位于香港的越秀大厦。不包括越秀金融大厦,物业总建筑面积约为97.4万平方米,分别位于中国广州市、上海市、武汉市、杭州市及香港市的核心商业区域。物业类型包括甲级写字楼、商业综合体、零售商业、酒店、服务式公寓、服装专业市场等。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

MarketingPulse and eTailingPulse open next Thursday

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Organised by the Hong Kong Trade Development Council (HKTDC), MarketingPulse and eTailingPulse – Asia’s premier annual e-commerce and marketing events – will be held concurrently on 19 March at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme "Generate New Growth", this year's conferences focus on how brands can rethink their growth strategies amid global market uncertainty, helping to turn challenges into forward momentum. From strategic insights to practical implementation, the events will comprehensively reveal new directions for growth, bringing together about 70 global e-commerce experts, marketing executives, brand representatives and advertising elites to share valuable insights and success stories relating to global marketing and e-commerce trends. Featuring 30 thematic sessions, seminars and demonstration sessions, the events will help to foster cross-sector exchange and boost collaboration within the industry.The rise of e-commerce has injected new momentum into global economic growth, while the government is actively encouraging small and medium-size enterprises (SMEs) to develop e-commerce capabilities that can enhance their market competitiveness. This year’s conferences will focus on the latest developments in e-commerce, helping participants seize growth opportunities in the current market environment through a dual-track approach that advances both e-commerce development and brand marketing. A lineup of experts will speak on topics such as agentic AI, lifestyle e-commerce, quick commerce and global brand expansion. They will examine innovation in e-commerce along with global marketing trends and emerging consumer opportunities, while exploring how the industry can generate new growth amid a rapidly evolving marketing landscape.Tech marketing expert shares insights on data-driven growthJinhee Lee, Chief Operating Officer of Olive Young, South Korea’s leading health and beauty brand, will present on the theme “Beyond Retail, Building an Ecosystem: Driving Collaborative Growth of Olive Young and K-Beauty”. Drawing on perspectives from both marketing and e-commerce, he will explain how seamless omnichannel operations and data-driven marketing strategies are being leveraged to build a high-growth ecosystem for Korean beauty brands, while continuously expanding their global footprint. Well-known for harnessing data to drive innovation, Mr Lee has spearheaded a series of digital transformation initiatives and integrated retail strategies, using technology to enable Olive Young to stay ahead of trends and become a leader in the global beauty market.Breaking new ground in marketing through the China experience and new retailAtour Group is a leading player in Chinese Mainland’s mid- to high-end hotel chain market. Its Founder, CEO & Chief Experience Officer, Haijun Wang, will focus on two key themes during his presentation: 1) Experience Differentiation Strategy — placing differentiated experiences at the core to build distinctive product and service offerings across both the hotel and retail businesses; and 2) Customer Segment Operations Strategy — using a core customer base that pursues a quality lifestyle as the connective thread to deeply integrate the hotel and retail businesses, thereby shaping a unique brand group model.Enhancing brand value through aesthetic intelligence in e-commercePauline Brown, former Chairman of LVMH North America, will share how to leverage "aesthetic intelligence" to elevate brand value, shape consumer perception and strengthen overall online-to-offline experiences and marketing strategies. She will also discuss how brands can continuously cultivate "taste" and aesthetic acumen and explain how aesthetics and elevated storytelling can be utilised to build truly compelling brands in a rapidly changing e-commerce and technological landscape.Exploring the latest trends in agentic AI and quick commerceQuick commerce and agentic AI are bringing unprecedented changes to the e-commerce market in the Chinese Mainland, continuously reshaping consumers' shopping patterns, habits and demands. Yatong Qiu, Vice President of Taobao&Tmall Group, Alibaba, will share on how brands and merchants can tackle demand through flexible merchandising strategies, real-time marketing and speed-oriented innovations to maintain competitiveness and seize time-sensitive opportunities. Meanwhile, Terry Li, Vertical General Manager of Smart Retail, Tencent, will take a deeper dive into agentic AI-driven e-commerce strategies. Looking from the perspectives of service providers and e-commerce ecosystems, he will share practical approaches and future innovation directions for agentic AI solutions, helping brands and businesses seize the initiative in the new era of e-commerce.Decoding cross-border growth and market entry strategies for ASEANAs ASEAN continues to rise as one of the world's most dynamic economic regions, enterprises from the Chinese Mainland and Hong Kong are actively setting their sights on Southeast Asia, particularly seeking growth opportunities through e-commerce channels. The conferences will feature a session titled “Decoding the Gateway to ASEAN: Cross Border Growth and Market Entry Strategies”, exploring strategies for entering the ASEAN market. Speakers including Luca Barni, SVP, Commercial, Lazada Group, will share their practical experiences in expanding within ASEAN. Attendees will get a comprehensive understanding of the growth opportunities and common pitfalls in this growing market, addressing e-commerce legal and regulatory challenges, as well as brand and product localisation strategies.Cracking the Threads audience engagement plus celebrity insightsThe recent rise of social platform Threads is further driving the evolution of brand marketing models. In the "Threads for Consumer and Audience Engagement" session, Kenie Kwok, Creative Strategy Lead at Meta, will share the latest trends in brand account management and user preferences from the platform's perspective. Actor and "Threads Admin" Ng Siu-hin will share his insights on how to stand out as a content creator, offering practical tips on building engagement with netizens from a creator's viewpoint. In addition, IN.DECIDE, renowned for managing social media platforms for multiple brands as an "admin", will analyse its promotional campaign for the film Peg O' My Heart, detailing how the virtual character "Choi San-keung" successfully broke the fourth wall with the audience.This year's "Meet the Celebrity” dialogue series has invited actor and singer-songwriter Louis Cheung to speak on the topic "Chasing the Golden Boy Within". He will share his career journey in personal brand management and talk about his multifaceted development across the acting, music and creative fields. Meanwhile, content creator and MUSE TV Founder Mayao will discuss how he strategically leverages innovative promotional approaches to market music works, generating broad and lasting public impact and driving sustainable market growth.Exploring the “healing economy" and IP marketingWhen engaging with younger generations, who place strong emphasis on emotional connection, brands must understand “oshikatsu culture”, where young people identify strongly as a fan of an idol, along with the healing trend and intellectual property (IP)-driven consumer behaviour. The session "Healing Economy and IP Marketing" will feature speakers including Yiying Wang, Founder and Designer of Noodoll Limited, who will explore how brands can keep abreast of the latest trends, such as designing sustainably interactive experiences and campaigns with an "oshikatsu mindset", incorporating healing elements into products or marketing to enhance resonance, and collaborating with popular IPs to boost reach and engagement, thereby deepening connections and relationships with younger demographics.The conferences will introduce a new feature, "e-Commerce Connect", showcasing the latest one-stop e-commerce solutions, with close to 30 local and international exhibitors. Additionally, a series of digital marketing and e-commerce workshops will enable participating brands to gain hands-on practical experience. Multiple networking activities will be organised, and participants can take advantage of one-to-one business matching services to facilitate cross-sector exchange and collaboration. The event will also feature live music performances, including a set from popular local singer James Ng.For more information on speakers and the detailed programme for the conferences, please visit: https://marketingpulse.hktdc.com/conference/mp/en. To request interviews with guest speakers, please email betsytse@raconteur.hk or molisalau@raconteur.hk.Photo download: https://bit.ly/3OU0UArPauline Brown, Former Chairman of LVMH North AmericaHaijun Wang, Founder and CEO of Atour Lifestyle HoldingsJinHee Lee, Chief Operating Officer of Olive YoungLouis Cheung, Actor and singer-songwriterNg Siu-hin, Artist and "Threads Admin"MarketingPulse and eTailingPulse will be held on 19 March at the Hong Kong Convention and Exhibition Centre. Pictured are the MarketingPulse and eTailingPulse events held in 2025Websites· MarketingPulse: https://marketingpulse.hktdc.com/conference/mp/en· Event schedule: https://marketingpulse.hktdc.com/conference/mp/en/programme· Speaker list: https://marketingpulse.hktdc.com/conference/mp/en/speaker· eTailingPulse: https://etailingpulse.hktdc.com/conference/etp/en· EntertainmentPulse: https://hkfilmart.hktdc.com/conference/hkfilmart/en Media enquiriesFor enquiries, please contact:Raconteur PR Agency:Betsy TseTel: (852) 9742 7338Email: betsytse@raconteur.hkMolisa LauTel: (852) 6187 7786Email: molisalau@raconteur.hkHKTDC Communication and Public Affairs Department:Clayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com